<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6538246</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0217497</article-id><article-id pub-id-type="publisher-id">PONE-D-19-01632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Bunyaviruses</subject><subj-group><subject>Rift Valley fever virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Bunyaviruses</subject><subj-group><subject>Rift Valley fever virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Bunyaviruses</subject><subj-group><subject>Rift Valley fever virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Bunyaviruses</subject><subj-group><subject>Rift Valley fever virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>RNA processing</subject><subj-group><subject>Alternative Splicing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>RNA processing</subject><subj-group><subject>Alternative Splicing</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>DNA transcription</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>DNA-binding proteins</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject><subj-group><subject>Gene Regulation</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Regulatory Proteins</subject><subj-group><subject>Transcription Factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject><subj-group><subject>Viral Gene Expression</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Microbial Genetics</subject><subj-group><subject>Viral Genetics</subject><subj-group><subject>Viral Gene Expression</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Genetics</subject><subj-group><subject>Viral Gene Expression</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Virus Effects on Host Gene Expression</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Transmission and Infection</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs</article-title><alt-title alt-title-type="running-head">mRNA expression and processing in RVFV infected cells</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Havranek</surname><given-names>Katherine E.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4548-0661</contrib-id><name><surname>White</surname><given-names>Luke Adam</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lanchy</surname><given-names>Jean-Marc</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8087-5362</contrib-id><name><surname>Lodmell</surname><given-names>J. Stephen</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Biological Sciences, The University of Montana, Missoula, MT, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Center for Biomolecular Structure and Dynamics, The University of Montana, Missoula, MT, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Ikegami</surname><given-names>Tetsuro</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Texas Medical Branch at Galveston, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>stephen.lodmell@umontana.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><issue>5</issue><elocation-id>e0217497</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Havranek et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Havranek et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0217497.pdf"/><abstract><p>Rift Valley fever virus (RVFV) is a negative-sense RNA virus belonging to the <italic>Phenuiviridae</italic> family that infects both domestic livestock and humans. The NIAID has designated RVFV as a Category A priority emerging pathogen due to the devastating public health outcomes associated with epidemic outbreaks. However, there is no licensed treatment or vaccine approved for human use. Therefore it is of great interest to understand RVFV pathogenesis in infected hosts in order to facilitate creation of targeted therapies and treatment options. Here we provide insight into the host-pathogen interface in human HEK293 cells during RVFV MP-12 strain infection using high-throughput mRNA sequencing technology. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differentially expressed genes showed robust innate immune and cytokine-mediated inflammatory pathway activation as well as alterations in pathways associated with fatty acid metabolism and extracellular matrix receptor signaling. We also analyzed the promoter regions of DEGs for patterns in transcription factor binding sites, and found several that are known to act synergistically to impact apoptosis, immunity, metabolism, and cell growth and differentiation. Lastly, we noted dramatic changes in host alternative splicing patterns in genes associated with mRNA decay and surveillance, RNA transport, and DNA repair. This study has improved our understanding of RVFV pathogenesis and has provided novel insight into pathways and signaling modules important for RVFV diagnostics and therapeutic development.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R15AI105737</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8087-5362</contrib-id><name><surname>Lodmell</surname><given-names>J. Stephen</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>P20GM103546</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8087-5362</contrib-id><name><surname>Lodmell</surname><given-names>J. Stephen</given-names></name></principal-award-recipient></award-group><funding-statement>This work was funded by National Institute of Allergy and Infectious Diseases (URL: <ext-link ext-link-type="uri" xlink:href="http://NIH.gov">NIH.gov</ext-link>) (grant R15AI105737 to JSL) and National Institute of General Medical Sciences (URL: <ext-link ext-link-type="uri" xlink:href="http://NIH.gov">NIH.gov</ext-link>) (grant P20GM103546) (S. Sprang, P.I.; JSL Pilot Project P.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="22"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic disease that was originally discovered in the Kenyan Rift basin in the 1930s [<xref rid="pone.0217497.ref001" ref-type="bibr">1</xref>]. The virus has since spread throughout Sub-Saharan Africa and has more recently extended its reach outside of the African continent into the Arabian Peninsula [<xref rid="pone.0217497.ref002" ref-type="bibr">2</xref>]. More than fifty mosquito vector species can transmit the virus, including species whose home range spans well into portions of the Americas, such as <italic>Aedes aegypti</italic> mosquitos that carry other viruses like Zika, chikungunya, yellow fever and dengue [<xref rid="pone.0217497.ref003" ref-type="bibr">3</xref>]. RVFV causes severe disease in both livestock and humans. Epidemics in livestock yield 10&#x02013;20% mortality in adults and cause what have been termed &#x02018;abortion storms&#x02019; in fetuses and neonates, since mortality rates can rise as high as 100% [<xref rid="pone.0217497.ref004" ref-type="bibr">4</xref>]. In humans, the virus causes an array of clinical manifestations ranging from mild flu-like illness to severe complications including blindness, meningoencephalitis, hemorrhagic fever and death [<xref rid="pone.0217497.ref005" ref-type="bibr">5</xref>]. High rates of human infection coincide with above average periods of rainfall and flooding, which provide ripe conditions for an overabundance of mosquito vectors. RVFV has already demonstrated both its potential for spread outside of endemic regions and its ability to cause devastating public health and economic impacts. Furthermore, there is no licensed vaccine for human use, although there is ongoing vaccine testing in livestock [<xref rid="pone.0217497.ref006" ref-type="bibr">6</xref>].</p><p>RVFV is a tri-segmented negative-sense single-stranded RNA virus belonging to the <italic>Phlebovirus</italic> genus within the <italic>Phenuiviridae</italic> family [<xref rid="pone.0217497.ref007" ref-type="bibr">7</xref>]. The viral genome consists of three segments designated large (L), medium (M) and small (S), which encode the viral RNA-dependent RNA polymerase, the viral glycoproteins Gn and Gc and nonstructural protein NSm, and the viral nucleocapsid protein N and the nonstructural virulence protein, NSs, respectively. These few viral proteins, in conjunction with host proteins, ensure that the virus can replicate its genome during a productive infection. Virus-host interaction is paramount for viral progeny production and therefore it is of great interest to understand how these interactions shape the cellular landscape during viral infection. The rising trend of high throughput mRNA sequencing has enabled a profound appreciation for the cellular transcriptomic overhaul that occurs as a result of disease progression, cancer state, or environmental condition [<xref rid="pone.0217497.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0217497.ref013" ref-type="bibr">13</xref>]. However, relatively few mRNA-seq studies to date have characterized the host response to viral infection. The studies that have risen to this challenge have revealed novel insights into host-pathogen dynamics [<xref rid="pone.0217497.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pone.0217497.ref018" ref-type="bibr">18</xref>]. A deeper understanding of the host response to viral infection will contribute to the development of effective treatment options and targeted therapies. In this study our objective was to characterize changes in gene expression that occur during RVFV infection, as well as alterations in transcription factor usage and host splicing.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Cell culture and viral infections</title><p>HEK293 cells were cultured in Dulbecco&#x02019;s Modified Eagle Medium (DMEM) with 10% fetal bovine serum and 1% penicillin/streptomycin. For experiments using MP-12 RVFV, 80&#x02013;90% confluent HEK293 cells were washed with phosphate-buffered saline (PBS) and overlaid with virus at the specified MOI in DMEM without serum or antibiotics and incubated for one hour at 37&#x000b0;C and 5% CO<sub>2</sub>. After incubation with virus the media was replaced with DMEM supplemented with 2% fetal bovine serum and the cells were maintained at 37&#x000b0;C and 5% CO<sub>2</sub> until time of harvest. Viral infection was confirmed using immunofluorescence targeting the viral nucleocapsid protein as well as RT-qPCR amplification of the viral small genome segment. The MP-12 vaccine strain of RVFV was kindly provided by Brian Gowen (Utah State University, Logan, UT). The virus stock was amplified once on Vero cells and portioned into small aliquots and frozen so that all experiments used the same passage of virus.</p></sec><sec id="sec004"><title>RNA Sequencing</title><p>Total RNA was extracted from infected and uninfected cells using the PureLink RNA Mini Kit (Thermo Fisher Scientific) and RNA integrity was verified using TapeStation 2200 Bioanalyzer (Agilent) and agarose gel electrophoresis. High quality RNA samples representing triplicate infected or mock-infected cells were submitted to Novogene for commercial RNA-sequencing (Novogene Beijing, China). Poly-A mRNA was selected from total RNA using oligo-dT bound magnetic beads and strand specific NEBNext Ultra RNA libraries were synthesized for paired-end 150 bp (PE 150) on an Illumina HiSeq 2000 platform (Illumina Inc.). Base calling was performed using CASAVA and raw data was stored as FASTQ files. Reads were filtered for quality and aligned to the GRCh-37 (hg19) genome using TopHat2 to generate BAM files [<xref rid="pone.0217497.ref019" ref-type="bibr">19</xref>]. DESeq2 R package was used to identify differentially expressed genes (DEGs) in MP-12 infected cells relative to mock infected cells [<xref rid="pone.0217497.ref020" ref-type="bibr">20</xref>]. For further differential expression analysis, we employed a threshold of p&#x0003c;0.05 and log2&#x0003e;1.8 (3.5 fold change). Since even these stringent parameters yielded a large number of DEGs, a ranked approach using lists organized by log2 fold change for up- and down- regulated genes was input for GOrilla and then REVIGO, which performed gene ontology analysis of differentially expressed genes and removal of redundant GO terms, respectively [<xref rid="pone.0217497.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0217497.ref022" ref-type="bibr">22</xref>]. KEGG pathway analysis of DEGs was analyzed by the Database for Annotation, Visualization and Integrated Discovery (DAVID) [<xref rid="pone.0217497.ref023" ref-type="bibr">23</xref>]. oPOSSUM3 was used in single site analysis (SSA) mode to detect conserved transcription factor binding sites in significantly differentially expressed genes [<xref rid="pone.0217497.ref024" ref-type="bibr">24</xref>]. The oPOSSUM3 default setting for gene-based analyses was used, in which all genes in the oPOSSUM database serve as background. The Mixture of Isoforms (MISO) framework was used for identification of alternatively spliced genes [<xref rid="pone.0217497.ref025" ref-type="bibr">25</xref>]. KEGG pathway analysis of differentially spliced genes was also carried out using DAVID.</p></sec><sec id="sec005"><title>Flow Cytometry</title><p>To establish infection and live/dead counts for cells harvested for RNA sequencing analysis, another set of HEK293 cells was either mock-infected or infected with RVFV MP-12 strain at an MOI = 0.1 and harvested at 48hpi with trypsin/EDTA. After quenching the trypsin with serum-containing media, cells were pelleted by centrifugation and resuspended in PBS (1 x 10<sup>6</sup> cells per tube; 1 ml PBS). Cells were then incubated in the dark with a live/dead cells differential staining kit according to the manufacturer's instructions (Thermo LIVE/DEAD Fixable Red Dead Cell Stain Kit). All incubations used to prepare samples for flow cytometry were carried out at room temperature in the dark with gentle agitation. After two PBS washes, cells were fixed with fixation buffer for 30 min according to the manufacturer's instructions (Thermo eBioscience intracellular fixation &#x00026; permeabilization buffer set). The fixed cells were permeabilized with two washes with permeabilization buffer. Cells were then incubated for 60 min with mouse monoclonal antibody directed against RVFV Gn protein (1:200 dilution in permeabilization buffer; BEI Resources). After two washes with permeabilization buffer, the cells were incubated for 30 min with a 1:200 dilution of goat anti-mouse green Alexa-Fluor 488-conjugated secondary antibody (Thermo). Finally, after two washes with permeabilization buffer, the cells pellets were resuspended in 1 ml PBS and stored at 4&#x000b0;C in the dark until flow cytometry analysis. Cells were analyzed on an LSR II (BD Biosciences) in the University of Montana Center for Translational Medicine. Data were analyzed with FlowJo 10 software (Tree Star, Ashland, OR).</p></sec><sec id="sec006"><title>Data</title><p>Sequence data analyses are supplied as supplemental information with this manuscript.</p></sec><sec id="sec007"><title>RT-qPCR</title><p>Total RNA was extracted using the PureLink RNA Mini Kit (Thermo Fisher Scientific) and 600ng of RNA was reverse transcribed using Superscript III First-Strand Synthesis SuperMix (Thermo Fisher Scientific) with random hexamers or gene specific primers according to the manufacturer&#x02019;s instructions. qPCR was performed using the Applied Biosystems Step One Real-Time PCR System. For relative RT-qPCR, RNA levels were normalized to GAPDH and fold change in expression was calculated using the &#x00394;&#x00394;CT method [<xref rid="pone.0217497.ref026" ref-type="bibr">26</xref>]. The effect of MP-12 infection on GAPDH expression is displayed as a supplementary figure to validate use of GAPDH as an internal control gene (<xref ref-type="supplementary-material" rid="pone.0217497.s009">S2 Fig</xref>). Quantitative RT-qPCR of the small genome segment was carried out as previously described and standard curves were generated using in vitro synthesized RNA [<xref rid="pone.0217497.ref027" ref-type="bibr">27</xref>]. Primers used in this study are as follows listed 5&#x02019; to 3&#x02019;: GAPDH (Qiagen Quantitect Primer Assay), IFNB: F- <monospace>AAACTCATGAGCAGTCTGCA</monospace>, R- <monospace>AGGAGATCTTCAGTTTCGGAGG</monospace>, CXCL10: F- <monospace>TGGCATTCAAGGAGTACCTCTCT</monospace>, R- <monospace>CTGATGCAGGTACAGCGTACG</monospace></p><p>IFIT2: F- <monospace>TGCACTGCAACCATGAGTGAGAACA</monospace>, R- <monospace>GCCAGTAGGTTGCACATTGTGGC</monospace>, mir210hg: F- <monospace>GGCAGATTTAGTGGACGCCT</monospace>, R- <monospace>CTCACTTCGCAGTGGTGACA</monospace>, NOG: F- <monospace>GTGCAAGTGCTCGTGCTAGA</monospace>, R- <monospace>GCTAGAGGGTGGTGGAACTG</monospace></p></sec><sec id="sec008"><title>RT-PCR</title><p>Validation of alternative splicing events via RT-PCR Primers were designed using Primer-BLAST [<xref rid="pone.0217497.ref028" ref-type="bibr">28</xref>], listed here (5&#x02019; to 3&#x02019;): F_RIOK3_Ex5 <monospace>CCGGTTCCCACTCCTAAAAAGGGC</monospace>; R_RIOK3_Ex10 <monospace>CCAGCATGCCACAGCATGTTATACTCAC</monospace>; F_TRA2B_Ex1 <monospace>AGGAAGGTGCAAGAGGTTGG</monospace>; R_TRA2B_Ex3 <monospace>TCCGTGAGCACTTCCACTTC</monospace>; F_CLK2_Ex3 <monospace>CCGGACATTTAGCCGCTCAT</monospace>; R_CLK2_Ex6 <monospace>TGGCCATGGTAGTCAAACCA</monospace>; F_DDX5_Ex11 <monospace>ATTGCTACAGATGTGGCCTCC</monospace>; R_DDX5_Ex12 <monospace>TGCCTGTTTTGGTACTGCGA</monospace>; F_18S_rRNA <monospace>GTAACCCGTTGAACCCCATT</monospace>; R_18S_rRNA <monospace>CCATCCAATCGGTAGTAGCG</monospace>. Cells were infected or mock infected and harvested after 48 hours, and RNA was isolated via TRIzol. cDNA was generated using 0.1 &#x003bc;g total RNA, Maxima H Minus reverse transcriptase (ThermoFisher), and random hexamer primer. The PCR reaction was comprised of 10<bold>&#x003bc;</bold>l Phusion Flash High-Fidelity PCR Master Mix (ThermoFisher), 1<bold>&#x003bc;</bold>l each primer (10mM), 2<bold>&#x003bc;</bold>l cDNA, and 7<bold>&#x003bc;</bold>l H<sub>2</sub>O. Amplification was achieved with one cycle at 98&#x000b0;C for one minute, and 30 cycles of denaturation at 98&#x000b0;C for one second followed by paired annealing and extension at 72&#x000b0;C for 15 seconds. RT-PCR reactions were analyzed via agarose gel electrophoresis (<xref ref-type="supplementary-material" rid="pone.0217497.s008">S1 Fig</xref>).</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Transcriptome profiling and differential expression in RVFV MP-12 infected cells</title><p>In the present study, mRNA-seq was performed to compare transcriptomes in RVFV infected and uninfected HEK293 cells. Cells were either mock-infected or infected with RVFV MP-12 strain at an MOI = 0.1 and total RNA was harvested at 48hpi. RVFV MP-12 is an attenuated vaccine candidate strain that allows viral work to be completed under BSL2 containment conditions. Immunofluorescence, flow cytometry, and RT-qPCR confirmed that most cells were infected at the time of harvest using this scheme and that harvested cells were live (<xref ref-type="fig" rid="pone.0217497.g001">Fig 1</xref>).</p><fig id="pone.0217497.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.g001</object-id><label>Fig 1</label><caption><title>RVFV MP-12 infection in HEK293 cells at MOI = 0.1.</title><p>A. Immunofluorescent detection of viral nucleocapsid protein in infected and mock-infected cells 48hpi. B. Flow cytometry analysis of the infection levels and live/dead cells ratio at 48hpi of mock-infected (left panel) and infected (right panel) cells. The X-axis represents the red fluorescence associated with the live/dead cell staining. Live cells are on the left, dead cells on the right of the vertical cut-off line. The Y-axis represents the green fluorescence associated with infection (<italic>i</italic>.<italic>e</italic>., presence of viral Gn protein). Infected cells are on the top, uninfected cells on the bottom of the horizontal cut-off line. The fraction (percent) of each of the four possible combinations (dead/live, uninfected/infected) is indicated in the corner of each quadrant. C. RT-qPCR absolute quantification of the viral sense small genome segment at timepoints post-infection. Each point represents the mean copy number during infections performed in triplicate.</p></caption><graphic xlink:href="pone.0217497.g001"/></fig><p>Our goal in this study was to specifically analyze differential transcriptional and alternative splicing landscapes during RVFV infection. A related but distinct study detailing differential expression and pathway analysis at time points up to 18h post-RVFV infection in HSEAC cells was recently published [<xref rid="pone.0217497.ref014" ref-type="bibr">14</xref>]. Here we were interested in capturing a composite of statistically significant splicing events and changes in transcription factor usage occurring post-infection, therefore a synchronous infection was not ideal for our purposes. At 48 hours after infection at MOI = 0.1, immunofluorescence and flow cytometry indicated that nearly all cells were infected, and few were dead (<xref ref-type="fig" rid="pone.0217497.g001">Fig 1</xref>). This infection scheme allowed us to capture RNA from cells at different stages of infection, which was appropriate for observing highly significant and pervasive RNA processing events.</p><p>Poly-A selected RNA from three biological replicates was used for paired-end library preparation and transcriptome sequencing on an Illumina HiSeq platform. Approximately 136 million raw reads and 131 million clean reads were generated on average per sample, with phred Q30 values averaging 90.5% (<xref ref-type="supplementary-material" rid="pone.0217497.s001">S1 Table</xref>). Reads were mapped to the hg19 genome using TopHat2, which resulted in assembly of &#x0003e;85% of reads across samples [<xref rid="pone.0217497.ref019" ref-type="bibr">19</xref>] (<xref ref-type="supplementary-material" rid="pone.0217497.s002">S2 Table</xref>). RVFV mRNAs do not contain poly-A signals, therefore it was not necessary to map reads to the viral genome, since only polyadenylated RNAs were used for library generation.</p><p>Differential expression comparison of infected and mock-infected cells was carried out using the DEGSeq2 R package [<xref rid="pone.0217497.ref020" ref-type="bibr">20</xref>] (<xref ref-type="supplementary-material" rid="pone.0217497.s003">S3</xref>, <xref ref-type="supplementary-material" rid="pone.0217497.s004">S4</xref> and <xref ref-type="supplementary-material" rid="pone.0217497.s005">S5</xref> Tables). A threshold of p&#x0003c;0.05 and log2&#x0003e;1.8 (3.5 fold change) yielded 3125 differentially expressed genes, 2909 upregulated (93%) and 216 (7%) downregulated genes (<xref ref-type="fig" rid="pone.0217497.g002">Fig 2A</xref>). <xref rid="pone.0217497.t001" ref-type="table">Table 1</xref> represents the top up- and down- regulated genes. The differential expression analysis was validated via RT-qPCR for 5 genes, 3 upregulated (CXCL10, IFIT2, IFNB) and 2 downregulated (MIR210hg, NOG) (<xref ref-type="fig" rid="pone.0217497.g002">Fig 2B</xref>). Gene expression during RVFV infection cannot be analyzed without taking into account the role of viral NSs protein. In infected cells, the 31kDa NSs is present in the cytoplasm as well as in the nucleus, where it forms filamentous structures mediated by the C-terminal domain [<xref rid="pone.0217497.ref029" ref-type="bibr">29</xref>]. NSs has been shown to suppress transcription on a global level through its interaction with transcription complex TFIIH components p44 and p62, which inhibits TFIIH complex assembly by sequestration of p44 and promotes posttranslational degradation of p62 [<xref rid="pone.0217497.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0217497.ref031" ref-type="bibr">31</xref>]. In addition to its role in transcription, TFIIH also plays roles in cell cycle control and DNA repair [<xref rid="pone.0217497.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pone.0217497.ref034" ref-type="bibr">34</xref>]. Despite these mechanisms, it is clear that there is an abundance of mRNA present at the 48h timepoint post-infection. In fact, the number of reads obtained from mock infected cells was only slightly higher than read count from MP-12 infected cells on average across the three replicates (<xref ref-type="supplementary-material" rid="pone.0217497.s001">S1 Table</xref>).</p><fig id="pone.0217497.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.g002</object-id><label>Fig 2</label><caption><title>Differentially expressed genes and associated gene ontology terms at 48hpi.</title><p>A. Volcano plot of DEGs illustrating significance cut-off set to log2 fold change of 1.8. DEGs validated by RT-qPCR are labeled. B. RT-qPCR confirmation of expression level changes in DEG analysis. C. GO terms associated with upregulated genes.</p></caption><graphic xlink:href="pone.0217497.g002"/></fig><table-wrap id="pone.0217497.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.t001</object-id><label>Table 1</label><caption><title>Top up- and down- regulated genes sorted according to log2 fold change.</title></caption><alternatives><graphic id="pone.0217497.t001g" xlink:href="pone.0217497.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" colspan="2" style="background-color:#DBDBDB" rowspan="1">Top up-regulated genes</th><th align="justify" colspan="2" style="background-color:#DBDBDB" rowspan="1">Top down-regulated genes</th></tr><tr><th align="justify" rowspan="1" colspan="1">Gene Symbol</th><th align="justify" rowspan="1" colspan="1">Log 2 fold change</th><th align="justify" rowspan="1" colspan="1">Gene Symbol</th><th align="justify" rowspan="1" colspan="1">Log 2 fold change</th></tr></thead><tbody><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">IFIT2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">8.8609</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">MIR210HG</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-3.9125</td></tr><tr><td align="justify" rowspan="1" colspan="1">OASL</td><td align="justify" rowspan="1" colspan="1">8.7374</td><td align="justify" rowspan="1" colspan="1">NOG</td><td align="justify" rowspan="1" colspan="1">-3.7649</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">CXCL10</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">8.1793</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">OR51E2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-3.2826</td></tr><tr><td align="justify" rowspan="1" colspan="1">IFI44</td><td align="justify" rowspan="1" colspan="1">7.9412</td><td align="justify" rowspan="1" colspan="1">RP6-24A23.7</td><td align="justify" rowspan="1" colspan="1">-3.2239</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">OAS2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">7.7257</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">RP11-214O1.2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-3.1586</td></tr><tr><td align="justify" rowspan="1" colspan="1">OAS1</td><td align="justify" rowspan="1" colspan="1">7.4817</td><td align="justify" rowspan="1" colspan="1">ZNF346-IT1</td><td align="justify" rowspan="1" colspan="1">-3.1292</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">MX2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">7.3722</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">KIF12</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-3.0213</td></tr><tr><td align="justify" rowspan="1" colspan="1">C6orf222</td><td align="justify" rowspan="1" colspan="1">7.2838</td><td align="justify" rowspan="1" colspan="1">IRS4</td><td align="justify" rowspan="1" colspan="1">-2.999</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">ITGAM</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">7.2273</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">C1orf95</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.9308</td></tr><tr><td align="justify" rowspan="1" colspan="1">FAP</td><td align="justify" rowspan="1" colspan="1">7.1594</td><td align="justify" rowspan="1" colspan="1">RP11-355I22.7</td><td align="justify" rowspan="1" colspan="1">-2.8618</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">LHFPL3-AS1</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">7.1383</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">IGFBP5</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.8572</td></tr><tr><td align="justify" rowspan="1" colspan="1">CCL5</td><td align="justify" rowspan="1" colspan="1">7.1212</td><td align="justify" rowspan="1" colspan="1">RP11-250B2.3</td><td align="justify" rowspan="1" colspan="1">-2.7806</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">SLC2A5</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">7.1094</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">KCNA2</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.7728</td></tr><tr><td align="justify" rowspan="1" colspan="1">IL16</td><td align="justify" rowspan="1" colspan="1">7.0972</td><td align="justify" rowspan="1" colspan="1">AC074212.5</td><td align="justify" rowspan="1" colspan="1">-2.7277</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">PKHD1</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">6.9233</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">RP11-148O21.6</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.7234</td></tr><tr><td align="justify" rowspan="1" colspan="1">ANGPT2</td><td align="justify" rowspan="1" colspan="1">6.8649</td><td align="justify" rowspan="1" colspan="1">RP11-148O21.3</td><td align="justify" rowspan="1" colspan="1">-2.6813</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">IFNB1</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">6.8447</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">POSTN</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.6773</td></tr><tr><td align="justify" rowspan="1" colspan="1">CPA2</td><td align="justify" rowspan="1" colspan="1">6.8341</td><td align="justify" rowspan="1" colspan="1">KDM5B-AS1</td><td align="justify" rowspan="1" colspan="1">-2.6659</td></tr><tr><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">CGA</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">6.8093</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">HILPDA</td><td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">-2.6617</td></tr><tr><td align="justify" rowspan="1" colspan="1">IFIH1</td><td align="justify" rowspan="1" colspan="1">6.7032</td><td align="justify" rowspan="1" colspan="1">RP11-148O21.4</td><td align="justify" rowspan="1" colspan="1">-2.6528</td></tr></tbody></table></alternatives></table-wrap><p>Upregulated genes are in good agreement with those from a transcriptome profiling study performed by Pinkham and colleagues with both MP-12 and ZH548 strains of RVFV over a shorter 18hr time-course of infection in HSEAC cells [<xref rid="pone.0217497.ref014" ref-type="bibr">14</xref>]. Their study showed that the most highly upregulated genes during both MP-12 and ZH548 infection were ISGs (interferon stimulated genes). The two most highly upregulated genes at 18hpi were interferon stimulated genes (ISGs) IFIT2 and OASL, and in our study at 48hpi those were also the top upregulated transcripts. Additional ISGs upregulated at 48hpi include the other 2&#x02019;-5&#x02019; oligoadenylate synthase (OAS) family members OAS1 and OAS2, IFI44, MX2, IFNB1 and IFIH1/MDA5. Many inflammatory cytokines and chemokines were also activated (CXCL10, CCL5, IL16, ANGPT2, CXCL11). Tripartite motif containing 22 (TRIM22) was also highly upregulated, and has previously been shown to play an important role in antiviral immunity during Influenza A virus (IAV) infection due to its ability to target the IAV nucleoprotein for degradation [<xref rid="pone.0217497.ref035" ref-type="bibr">35</xref>]. Other upregulated genes were involved in cell adhesion (ITGAM) and microtubule motor activity (DNAH12), Wnt signaling (FAP), membrane transport (SLC2A5, NPC1L1, LAT2), metabolism (CPA2, PYGM) and apoptosis (XAF1).</p><p>Downregulated genes comprised genes involved in a diverse array of cellular functions. The most highly downregulated gene was MIR210HG, a microRNA that is upregulated in several cancers and is critical for regulating the hypoxic response [<xref rid="pone.0217497.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0217497.ref037" ref-type="bibr">37</xref>]. The hypoxia-induced lipid droplet associated HILPDA was also highly downregulated in our study and the study by Pinkham and colleagues. Downregulation of these factors is interesting, since RVFV infection stimulates oxidative stress [<xref rid="pone.0217497.ref038" ref-type="bibr">38</xref>]. In addition to its role in altering host cell transcription, virulence factor NSs is also known to interact with the mitochondria leading to redox imbalance and reactive oxygen species production, which leads to activation of NF-&#x003ba;B (p65) and p53 [<xref rid="pone.0217497.ref039" ref-type="bibr">39</xref>]. Ionotropic glutamate receptors (GRIA3, GRID2), a potassium-voltage gated channel (KCNA2), kinesin family member 12 (KIF12), and several long noncoding RNAs (RP11-214O1.2, RP11-355I22.7, RP11-250B2.3, RP11-148O21.6, AC083843.1) were also significantly downregulated.</p></sec><sec id="sec011"><title>Gene ontology and KEGG pathway analysis</title><p>Gene ontology (GO) analysis of differentially expressed genes was performed using GOrilla, which allows the user to input a ranked list of target genes for analysis, and redundant GO terms were removed using REVIGO [<xref rid="pone.0217497.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0217497.ref022" ref-type="bibr">22</xref>]. Using GOrilla for a large list of genes, input of genes ranked by their log2 fold change values outputs GO terms more significantly enriched in highly differentially expressed genes. GO analysis of upregulated genes using a single ranked list of genes and a p-value threshold of 10<sup>&#x02212;3</sup> illustrates, as expected, that the immune response is highly enriched upon infection as well as cell surface receptor signaling and signal transduction (<xref ref-type="fig" rid="pone.0217497.g002">Fig 2C</xref>). The much shorter list of downregulated genes showed no significant enrichment using the same parameters.</p><p>KEGG pathway analysis using DAVID for all significantly differentially expressed genes indicated that several pathways, inclucing many pathways involved in the type I IFN response (NF-&#x003ba;B signaling, TNF signaling, toll-like receptor signaling, RIG-I like receptor signaling, cytosolic DNA-sensing) were transcriptionally modified post-infection (<xref rid="pone.0217497.t002" ref-type="table">Table 2</xref>). As is the case with canonical type I IFN activation, it appears that IFN signaling activated the JAK/STAT pathway, which in turn upregulated interferon stimulated genes (ISGs). Pathway analysis also showed robust activation of the cytokine-mediated inflammatory response (cytokine-cytokine receptor interaction, chemokine signaling, NOD-like receptor signaling). Linoleic and arachidonic acid metabolism pathways were also altered, which could indicate that arachidonic acid-derived eicosanoids influenced the immune and inflammatory response during RVFV infection, as was previously discovered for respiratory viruses [<xref rid="pone.0217497.ref040" ref-type="bibr">40</xref>]. PI3K/AKT/mTOR signaling was also altered upon infection, consistent with prior work that showed RVFV infection attenuates Akt and downstream mTORC1 activity [<xref rid="pone.0217497.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0217497.ref042" ref-type="bibr">42</xref>]. Lastly, extracellular matrix (ECM) -receptor interaction pathways were modified during infection. Further investigation of the involvement of ECM receptor signaling during infection could yield insight into viral entry and cell to cell spread, which is an understudied area for RVFV.</p><table-wrap id="pone.0217497.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.t002</object-id><label>Table 2</label><caption><title>KEGG pathways analysis of differentially expressed genes.</title></caption><alternatives><graphic id="pone.0217497.t002g" xlink:href="pone.0217497.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">KEGG Pathway</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Cytokine-cytokine receptor interaction</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.80E-14</td></tr><tr><td align="left" rowspan="1" colspan="1">Complement and coagulation cascades</td><td align="right" rowspan="1" colspan="1">2.40E-05</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Jak-STAT signaling pathway</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.70E-05</td></tr><tr><td align="left" rowspan="1" colspan="1">ECM-receptor interaction</td><td align="right" rowspan="1" colspan="1">2.00E-04</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">NF-kappa B signaling pathway</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.00E-04</td></tr><tr><td align="left" rowspan="1" colspan="1">Neuroactive ligand-receptor interaction</td><td align="right" rowspan="1" colspan="1">2.20E-04</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Protein digestion and absorption</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.30E-04</td></tr><tr><td align="left" rowspan="1" colspan="1">Linoleic acid metabolism</td><td align="right" rowspan="1" colspan="1">6.90E-04</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Hematopoietic cell lineage</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">4.10E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">Chemokine signaling pathway</td><td align="right" rowspan="1" colspan="1">4.20E-03</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Toll-like receptor signaling pathway</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">5.80E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">Osteoclast differentiation</td><td align="right" rowspan="1" colspan="1">6.00E-03</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">TNF signaling pathway</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">6.40E-03</td></tr><tr><td align="left" rowspan="1" colspan="1">Arachidonic acid metabolism</td><td align="right" rowspan="1" colspan="1">7.10E-03</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Phenylalanine metabolism</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.40E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium signaling pathway</td><td align="right" rowspan="1" colspan="1">1.70E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Fat digestion and absorption</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.00E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">NOD-like receptor signaling pathway</td><td align="right" rowspan="1" colspan="1">2.60E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Cytosolic DNA-sensing pathway</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.60E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukocyte transendothelial migration</td><td align="right" rowspan="1" colspan="1">2.70E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Phototransduction</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">2.90E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">Steroid hormone biosynthesis</td><td align="right" rowspan="1" colspan="1">3.20E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Tyrosine metabolism</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">3.30E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">PI3K-Akt signaling pathway</td><td align="right" rowspan="1" colspan="1">3.60E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Serotonergic synapse</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">3.80E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">Transcriptional misregulation in cancer</td><td align="right" rowspan="1" colspan="1">4.20E-02</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Natural killer cell mediated cytotoxicity</td><td align="right" style="background-color:#D9D9D9" rowspan="1" colspan="1">4.40E-02</td></tr><tr><td align="left" rowspan="1" colspan="1">RIG-I-like receptor signaling pathway</td><td align="right" rowspan="1" colspan="1">4.60E-02</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec012"><title>Transcription factor binding sites represented in differentially expressed genes</title><p>As mentioned previously, the viral NSs protein is a major virulence factor that dramatically alters the host-pathogen interface during infection. Its primary biological functions include inhibition of general transcription, suppression of IFNB promotor activation, and degradation of PKR. Although NSs inhibits general transcription and specifically that occurring from IFNB promoters, it is clear that the cell can at least partially overcome NSs&#x02019;s transcriptional shutdown at this timepoint post infection. In order to investigate and categorize the types of genes that may escape NSs&#x02019;s block on general transcription, we looked for overrepresented transcription factor binding sites (TFBS) in the promoter regions of up- and down- regulated genes using oPOSSUM-3 software in Single-Site Analysis (SSA) mode [<xref rid="pone.0217497.ref024" ref-type="bibr">24</xref>] (<xref ref-type="supplementary-material" rid="pone.0217497.s006">S6 Table</xref>). SSA is used to find transcription factor binding motif enrichment in a given list of genes and assessed relative to motif enrichment in a background list of genes. Z-scores in conjunction with p-values are used to determine if a particular TFBS that occurs in the foreground set differs significantly from the expected occurrence in the background. Using a threshold Z-score of &#x0003e; 10 and a p-value of &#x0003c; 0.05, we discovered that just under 20 TFBS were significantly enriched in our DEGs (<xref ref-type="fig" rid="pone.0217497.g003">Fig 3A</xref>). In order to deduce synergistic interactions and functional networks associated with the transcription factors that interact with the identified binding sites, we performed STRING analyses where network edges represent interaction partners and thicker lines correspond to higher confidence interactions (<xref ref-type="fig" rid="pone.0217497.g003">Fig 3B</xref>). Consistent with the analysis of GO terms associated with DEGs, we found TFBS that are important for regulation of fatty acid metabolism, including PPARG, RXRA and ZNF423 [<xref rid="pone.0217497.ref043" ref-type="bibr">43</xref>]. Interestingly, ZNF423 also interacts with SMAD1-SMAD4 complex, which is involved in BMP and TGF-&#x003b2; signaling that regulates cell growth and differentiation as well as apoptosis. The SMAD family of transcription factors were also recently shown to be phosphorylated as a result of RVFV infection [<xref rid="pone.0217497.ref044" ref-type="bibr">44</xref>]. Further studies will be needed in order to determine whether synergy exists between ZNF423 and activated SMADs that influences RVFV infection.</p><fig id="pone.0217497.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.g003</object-id><label>Fig 3</label><caption><title>Enriched transcription factor binding sites present in differentially expressed genes.</title><p>A. Statistically significant TFBS are represented in the upper-right quadrant with Z score &#x0003e;10 and p-value &#x0003e;0.05. B. STRING network analysis of statistically significant TFBS. Network edges represent interaction partners and increased line thickness at edges indicates higher confidence interactions.</p></caption><graphic xlink:href="pone.0217497.g003"/></fig><p>A high confidence axis represented in the STRING network is the canonical NF-&#x003ba;B transcription factors RELA (p65) and NFKB1 (p50), which form heterodimeric complexes that act as transcriptional activators important for innate immunity, inflammation, apoptosis and cell growth and differentiation. SP1 connents to this axis, and although it is involved in a variety of biological processes and binding sites are present in many housekeeping genes, it has been implicated in cell cycle arrest and p-53 dependent apoptosis as well as in switching on early innate immune transcription [<xref rid="pone.0217497.ref045" ref-type="bibr">45</xref>]. ESR1 is also represented in this axis and is known to interact with NF-&#x003ba;B transcription factors in order to influence progression of breast cancer to advanced stage and metastatic disease [<xref rid="pone.0217497.ref046" ref-type="bibr">46</xref>]. However, the synergy between ESR1 and NF-&#x003ba;B during viral infection has not been extensively studied. During a transcriptional profiling study of Influenza A infection in lung epithelial cells, however, ESR1 was noted as a gene whose regulation was altered during NS1 deletion mutant viral infection [<xref rid="pone.0217497.ref047" ref-type="bibr">47</xref>]. Since the viral NS1 protein is a virulence factor responsible for repressing the host antiviral response in several ways, this study along with our work may indicate that ESR1 could play an important and underappreciated role in host activation or regulation of the antiviral response. ESR1 expression fluctuates during pregnancy, meaning that ESR1 has the potential to be uniquely important during RVFV infection, which is associated with high levels of abortion and neonatal death in pregnant ruminants [<xref rid="pone.0217497.ref048" ref-type="bibr">48</xref>].</p></sec><sec id="sec013"><title>Changes in host alternative splicing during viral infection</title><p>Alternative splicing (AS) of pre-mRNAs is a critical mechanism for regulating gene expression and expanding proteome diversity. Recent studies indicate that viral infection can cause marked changes in host splicing patterns, which results from the altered post-transcriptional program undertaken by the host as a response to invasion, but also many viruses have evolved methods to interfere with and modulate host splicing [<xref rid="pone.0217497.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0217497.ref051" ref-type="bibr">51</xref>]. To determine whether AS might play a role in RVFV pathogenesis, we examined differences in splicing patterns between MP-12 infected and uninfected cells using a program called MISO (Mixture of Isoforms), which estimates differential spliced isoform expression and confidence intervals using &#x003a8; values and Bayes factors, respectively [<xref rid="pone.0217497.ref025" ref-type="bibr">25</xref>] (<xref ref-type="supplementary-material" rid="pone.0217497.s007">S7 Table</xref>). Analysis yielded 1499 differential AS events between infected and uninfected cells using threshold &#x003a8; of &#x0003e;0.2 and BF &#x0003e;10. MISO categorizes isoforms as being one of five different splicing event types: alternative 5&#x02019; splice site selection (A5SS), alternative 3&#x02019; splice site selection (A3SS), mutually exclusive exons (MXE), retainied introns (RI), and skipped exons (SE). The analyses yielded SE events as the dominant splicing pattern at 783 events, which is just over half the total number of events (<xref ref-type="fig" rid="pone.0217497.g004">Fig 4A</xref>). Additionally, analyses revealed 275 RI, 168 A3SS, 137 A5SS and 136 MXE events (<xref ref-type="fig" rid="pone.0217497.g004">Fig 4A</xref>). While most genes had only one event per gene (n = 979), there were many genes that had multiple AS events per gene. These include GUSBP11 with 7 events, EEF1D and TRA2A with 6 events, WASH7P with 5 events, and 216 genes with 4, 3 or 2 events.</p><fig id="pone.0217497.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.g004</object-id><label>Fig 4</label><caption><title>Alternative splicing events induced by viral infection.</title><p>A. Significant AS events in infected compared with mock-infected cells. Splicing pattern types identified by the MISO algorithm are shown. B. Verification of AS events using RT-PCR with PCR primers flanking the spliced region. IGV was used to visualize mRNA-seq transcripts and the vertical axis represents the quantity of mapped reads for each condition. Red arrows indicate the primer amplicon region, except for RIOK3, where a larger region was amplified between exons 5 and 10.</p></caption><graphic xlink:href="pone.0217497.g004"/></fig><p>Several splicing events were validated via RT-PCR using primers flanking the splicing events of interest (<xref ref-type="fig" rid="pone.0217497.g004">Fig 4B</xref>). These events also produced interesting changes in the mRNA transcripts that would result in intriguing functional outcomes. For example, Rio kinase 3 (RIOK3) undergoes alternative 5&#x02019; splice site selection in exon 8 in infected cells, which generates a frameshift and introduces a premature termination codon in exon 9. This truncated RIOK3 transcript could be a target for nonsense mediated decay, or, if it were translated, it would be predicted to produce a C-terminally truncated protein product that lacks almost the entire kinase domain. Interestingly, RIOK3 has been implicated as an important player in the host antiviral response and thus this splicing event could have important regulatory consequences for these pathways post-infection [<xref rid="pone.0217497.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0217497.ref053" ref-type="bibr">53</xref>].</p><p>Transformer 2 beta homolog (TRA2B) exhibits decreased exon 2 skipping in infected cells. This demonstrates incidence of an autoregulatory splicing event that has been previously characterized. TRA2B is an SR-like protein responsible for altering splice site selection in a variety of transcripts in a concentration dependent manner. As is the case with most splicing factors, their expression must be tightly regulated, as misregulation is associated with various disorders. TRA2B uses a negative feedback autoregulatory mechanism to activate inclusion of its own exon 2. Inclusion of exon 2 generates the TRA2B4 splice variant, which is not translated into protein [<xref rid="pone.0217497.ref054" ref-type="bibr">54</xref>]. In infected cells, the decreased incidence of exon 2 skipping seems to indicate production of the non-functional TRA2B4 variant, perhaps the result of high TRA2B protein expression regulating its own splicing and downstream expression.</p><p>Similar to TRA2B, CDC like kinase 2 (CLK2) also autoregulates its protein expression by promoting skipping of its own exon 4. This event generates a frameshift which renders the CLK2 mRNA transcript a target of the nonsense-mediated decay machinery and is thus not translated into functional protein [<xref rid="pone.0217497.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0217497.ref056" ref-type="bibr">56</xref>]. In infected cells there is an increase in exon 4 skipping, which appears to indicate that these CLK2 transcripts are not translated. Lastly we validated the decrease in intron retention noted during viral infection in DEAD-box helicase 5 (DDX5) between exons 11 and 12. Interestingly, this intron is highly conserved and variably included in DDX5 transcripts across tissues, indicating an important functional role [<xref rid="pone.0217497.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0217497.ref058" ref-type="bibr">58</xref>]. Indeed the intron has been shown to encode a processed miRNA that coimmunoprecipitates with Ago2, although endogenous targets have yet to be characterized [<xref rid="pone.0217497.ref059" ref-type="bibr">59</xref>].</p><p>Most of these alternatively spliced genes were not differentially expressed at the level of transcription, indicating that differential expression and AS are independent regulatory mechanisms occurring post-infection (<xref ref-type="fig" rid="pone.0217497.g005">Fig 5A</xref>). To understand the functional consequences of these splicing events, we implemented GO enrichment analysis using all AS genes. GO terms with p-values of &#x0003c;0.05 were subjected to Revigo in order to cluster and delete redundant GO terms. REVIGO scatterplot analysis shows that most AS genes are involved in cellular metabolic and biosynthetic processes, as well as RNA processing (<xref ref-type="fig" rid="pone.0217497.g005">Fig 5B</xref>). KEGG pathways significantly enriched amongst AS genes were mRNA surveillance pathway, Fanconi Anemia pathway, Hippo signaling, and RNA transport.</p><fig id="pone.0217497.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0217497.g005</object-id><label>Fig 5</label><caption><title>Expression and GO analysis of alternatively spliced transcripts.</title><p>A. Alternative splicing events plotted with Bayes factor represented on the y-axis and differential expression on the x-axis. B. REVIGO scatterplot analysis of overrepresented GO terms associated with AS genes. The two-dimensional plot clusters GO terms based on semantic similarities. Bubble color corresponds to the p-value; size indicates the frequency of the GO term within the database.</p></caption><graphic xlink:href="pone.0217497.g005"/></fig></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>This study has detailed the transcriptional modifications and alternative splicing events that occur in RVFV MP-12 infected HEK293 cells. We demonstrate that many genes are differentially expressed and we identify GO and KEGG pathways as well as transcription factor binding sites in DEGs. One of the main themes that appeared in this analysis was activation of innate immunity and inflammation. ISGs comprised a majority of top up-regulated genes, and we confirmed an increase in several of these genes using RT-qPCR. In addition, KEGG pathways associated with DEGs included NF-kB signaling, TNF signaling, toll-like receptor signaling, RIG-I like receptor signaling, cytosolic DNA-sensing, JAK-STAT signaling, cytokine-cytokine receptor interaction, chemokine signaling, NOD-like receptor signaling.</p><p>Several studies have highlighted the importance of the antiviral response in determining viral pathogenesis and disease outcome as a result of RVFV infection [<xref rid="pone.0217497.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0217497.ref061" ref-type="bibr">61</xref>]. Age-associated susceptibility to RVFV has been demonstrated in humans, livestock and laboratory animals, which suggests that host resistance may be mediated by the more robust type I interferon system present in mature adults [<xref rid="pone.0217497.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0217497.ref063" ref-type="bibr">63</xref>]. Like most negative-sense RNA viruses, RVFV does not produce significant levels of dsRNA during infection [<xref rid="pone.0217497.ref064" ref-type="bibr">64</xref>]. Nevertheless, RVFV activates PKR, and the 5&#x02019; triphosphate groups present at the RVFV genome termini act as a strong activators of RIG-I-dependent interferon induction, culminating in ISG induction [<xref rid="pone.0217497.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0217497.ref066" ref-type="bibr">66</xref>]. Despite the fact that NSs is a powerful inhibitor of PKR signaling and IFNB promoter activation, our work shows that the host still mounts a significant antiviral response by 48hpi. Global transcriptome profiling during Schmallenberg virus infection (SBV) showed dampened activation of IFN stimulated genes in SBV infection as opposed to infection with SBV lacking the NSs gene [<xref rid="pone.0217497.ref015" ref-type="bibr">15</xref>]. However, similar to the results shown here, their work also indicated that some antiviral genes escape NSs suppression during SBV infection.</p><p>It has been previously shown that NSs acts as a global inhibitor of transcription via its interaction with TFIIH complex components and by binding with SAP30 to prevent IFNB promoter activation [<xref rid="pone.0217497.ref067" ref-type="bibr">67</xref>]. We observed only a modest decrease in total reads obtained from MP-12 infected cells when compared with mock-infected cells, and most genes in the DEG analysis were actually upregulated during infection. A similar trend was observed by Pinkham and coworkers during mRNA-seq analysis comparing MP-12 and ZH548 strains of RVFV in HSEACs at timepoints post-infection, where it was noted that, although the differences were not statistically significant, fewer reads were obtained during later times post-infection, and DEG analysis at 18hpi yielded more upregulated than downregulated genes [<xref rid="pone.0217497.ref014" ref-type="bibr">14</xref>]. Their study did, however, support the role of NSs as a general inhibitor of transcription, since RT-qPCR analysis of several housekeeping genes at 9 and 18 hpi exhibited decreased expression relative to mock infected cells. Chromatin immunoprecipitation with promoter sequence microarray analysis of NSs showed that several promoter regions interacted with NSs and that the interaction corresponds to decreased expression of the corresponding genes, with the notable exception of genes associated with the coagulation cascade, which actually exhibited increased expression as a function of NSs binding [<xref rid="pone.0217497.ref068" ref-type="bibr">68</xref>]. Interestingly, KEGG analysis in our study indicated alteration in the complement and coagulation pathway at 48hpi, possibly corroborating the ability of NSs to stimulate transcription of some gene categories. While certain families of genes were overrepresented among NSs interaction regions in the ChIP study, NSs only specifically interacted with about 10% of promoter regions represented in the array [<xref rid="pone.0217497.ref068" ref-type="bibr">68</xref>]. It is possible that at later timepoints post-infection, host antiviral response gene overexpression masks the transcriptional inhibition ability of NSs which may be more effective at earlier timepoints post-infection. Furthermore, mRNA-seq analysis at 48hpi represents a single snapshot in time, not providing any information to distinguish between newly transcribed mRNAs and mRNAs that are still present due to a longer half-life or regulation by mRNA decay mechanisms. A detailed study with multiple timepoints post-infection, as well as incorporating an infection scheme using an NSs-deletion mutant virus could aid in our understanding of the role of NSs in transcription.</p><p>Another prevalent theme across our analyses were altered pathways associated with linoleic and arachidonic acid metabolism, which appeared in KEGG analysis of the DEGs. Also, TFBS overrepresented in the DEGs belonged to TFs known to regulate fatty acid metabolism. The linoleic and arachidonic acid metabolic pathways are connected, as non-essential arachidonic acid can be obtained from diet or by desaturation and elongation of the essential fatty acid linoleic acid. Free arachidonic acid is an important lipid second messenger involved in cellular signaling and arachidonic acid-derived eicosanoids are critical for immune function. In particular, eicosanoids cooperate with cytokines and chemokines to influence inflammation [<xref rid="pone.0217497.ref069" ref-type="bibr">69</xref>]. For this reason, eicosanoids have been shown to be critical contributors to viral pathogenesis during respiratory virus infections, where severe virus-induced inflammation can determine the outcome of infection [<xref rid="pone.0217497.ref040" ref-type="bibr">40</xref>]. Work performed in patients infected with the hemorrhagic fever virus severe fever with thrombocytopenia syndrome virus (SFTSV), which is closely related to RVFV, has suggested that disease progression and severity are linked to inflammatory cytokine and chemokine production imbalance [<xref rid="pone.0217497.ref070" ref-type="bibr">70</xref>]. Eicosanoids are being investigated as potential antiviral therapies for respiratory viruses, and our work indicates that their role during RVFV infection may warrant exploration [<xref rid="pone.0217497.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0217497.ref071" ref-type="bibr">71</xref>].</p><p>Our analysis also showed that a surprising array of mRNA transcripts are alternatively spliced during infection. Preliminary analysis and validation of several events indicated that these are programmed events that have been previously characterized and have functional consequences for gene expression, as opposed to abberant events that could be construed as a byproduct of cellular disarray due to infection. Alternative splicing events occurring during infection were primarily in genes with GO terms related to RNA processing, and this was evident in the validated splicing events. Notably, DDX5, TRA2B and CLK2 all play important roles in RNA splicing and gene expression [<xref rid="pone.0217497.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0217497.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0217497.ref072" ref-type="bibr">72</xref>&#x02013;<xref rid="pone.0217497.ref074" ref-type="bibr">74</xref>]. For these three genes, the alternative splicing patterns adopted during infection yielded transcripts that have been previously shown to be non-functional. Alternative splicing is appreciated widely as a mechanism for expanding genetic economy and proteome diversity. However, the coupling of alternative splicing with RNA decay pathways is also an important mechanism by which the cell can post-transcriptionally control gene expression. Although not extensively studied to this point, it is possible that this is an important mechanism adopted by the cell to fine-tune gene expression in the wake of viral infection. It is also important to acknowledge that viruses have adopted multifarious methods to thwart or hijack host RNA transcription, splicing, processing and decay [<xref rid="pone.0217497.ref075" ref-type="bibr">75</xref>&#x02013;<xref rid="pone.0217497.ref079" ref-type="bibr">79</xref>]. Yet, a role for RVFV in interference with host splicing has not yet been described. As more transcriptome profiling studies are conducted during viral infection, it will be of great interest to examine the global splicing environment in order to better understand the host and viral mechanisms at play.</p><p>In conclusion, this study provides a transcriptomic perspective of RVFV infected HEK293 cells after two days of infection. Despite the powerful ability of NSs to derail the host immune response via inhibition of the IFNB promoter as well as NSs-driven PKR degradation, we have illustrated that the cell still mounts a robust antiviral response at this late timepoint post-infection. We further illustrate that functionally related groups of transcription factor binding sites were represented in DEGs, highlighting specific cellular priorities at this point during infection. Future transcriptome profiling studies incorporating an infection scheme with an NSs deletion MP-12 strain would better discern the effects of NSs. In addition, this is the first study to characterize significant global splicing changes that occur in RVFV infected cells, and we demonstrate that some of these splicing changes lead to non-productive trancripts. This emphasizes the importance of future studies addressing the functional consequences of the splicing overhaul that occurs as a result of infection.</p></sec><sec sec-type="supplementary-material" id="sec015"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0217497.s001"><label>S1 Table</label><caption><title>Data quality summary.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s002"><label>S2 Table</label><caption><title>Mapping statistics.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s003"><label>S3 Table</label><caption><title>Gene expression FPKM values for all genes.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s004"><label>S4 Table</label><caption><title>Differential expression: Downregulated genes.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s005"><label>S5 Table</label><caption><title>Differential expression: Upregulated genes.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s006"><label>S6 Table</label><caption><title>Transcription factor binding sites in DEGs.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s006.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s007"><label>S7 Table</label><caption><title>MISO events.</title><p>(XLSX)</p></caption><media xlink:href="pone.0217497.s007.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s008"><label>S1 Fig</label><caption><title>Original gel: validation of alternative splicing events found in MISO.</title><p>(TIF)</p></caption><media xlink:href="pone.0217497.s008.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0217497.s009"><label>S2 Fig</label><caption><title>Validation of GAPDH as an internal control gene for relative RT-qPCR.</title><p>(TIFF)</p></caption><media xlink:href="pone.0217497.s009.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to gratefully acknowledge funding support for this work from NIH grants R15AI105737 to JSL and P20GM103546 (S. Sprang, P.I.; JSL Pilot Project P.I.). We wish to thank Jim Reed and Dr. Scott Wetzel for their gracious help with discussions and analysis of the flow cytometry samples. The following reagent was obtained from the Joel M. Dalrymple&#x02013;Clarence J. Peters USAMRIID Antibody Collection through BEI Resources, NIAID, NIH: Monoclonal Anti-Rift Valley Fever Virus Gn Glycoprotein, Clone 3C10 (produced <italic>in vitro</italic>), NR-43186.</p></ack><ref-list><title>References</title><ref id="pone.0217497.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Daubney</surname><given-names>RJ</given-names></name>, <name><surname>Hudson</surname><given-names>J.R.</given-names></name> and <name><surname>Garnham</surname><given-names>P.C.</given-names></name>
<source>Journal of Pathology and Bacteriology</source>. <year>1931</year>;<volume>34</volume>:<fpage>545</fpage>&#x02013;<lpage>79</lpage>.</mixed-citation></ref><ref id="pone.0217497.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Madani</surname><given-names>TA</given-names></name>, <name><surname>Al-Mazrou</surname><given-names>YY</given-names></name>, <name><surname>Al-Jeffri</surname><given-names>MH</given-names></name>, <name><surname>Mishkhas</surname><given-names>AA</given-names></name>, <name><surname>Al-Rabeah</surname><given-names>AM</given-names></name>, <name><surname>Turkistani</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics</article-title>. <source>Clin Infect Dis</source>. <year>2003</year>;<volume>37</volume>(<issue>8</issue>):<fpage>1084</fpage>&#x02013;<lpage>92</lpage>. Epub 2003/10/03. <pub-id pub-id-type="doi">10.1086/378747</pub-id> .<?supplied-pmid 14523773?><pub-id pub-id-type="pmid">14523773</pub-id></mixed-citation></ref><ref id="pone.0217497.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Linthicum</surname><given-names>KJ</given-names></name>, <name><surname>Britch</surname><given-names>SC</given-names></name>, <name><surname>Anyamba</surname><given-names>A</given-names></name>. <article-title>Rift Valley Fever: An Emerging Mosquito-Borne Disease</article-title>. <source>Annu Rev Entomol</source>. <year>2016</year>;<volume>61</volume>:<fpage>395</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-ento-010715-023819</pub-id> .<?supplied-pmid 26982443?><pub-id pub-id-type="pmid">26982443</pub-id></mixed-citation></ref><ref id="pone.0217497.ref004"><label>4</label><mixed-citation publication-type="book"><name><surname>Coetzer</surname><given-names>JAW</given-names></name>, <name><surname>Tustin</surname><given-names>RC</given-names></name>. <source>Infectious diseases of livestock</source>. <edition>2nd ed</edition>
<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2004</year>.</mixed-citation></ref><ref id="pone.0217497.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ikegami</surname><given-names>T</given-names></name>, <name><surname>Makino</surname><given-names>S</given-names></name>. <article-title>The Pathogenesis of Rift Valley Fever</article-title>. <source>Viruses</source>. <year>2011</year>;<volume>3</volume>(<issue>5</issue>):<fpage>493</fpage>&#x02013;<lpage>519</lpage>. Epub 2011/06/15. <pub-id pub-id-type="doi">10.3390/v3050493</pub-id>
<?supplied-pmid 21666766?><pub-id pub-id-type="pmid">21666766</pub-id></mixed-citation></ref><ref id="pone.0217497.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Indran</surname><given-names>SV</given-names></name>, <name><surname>Ikegami</surname><given-names>T</given-names></name>. <article-title>Novel approaches to develop Rift Valley fever vaccines</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2012</year>;<volume>2</volume>:<fpage>131</fpage>
<pub-id pub-id-type="doi">10.3389/fcimb.2012.00131</pub-id>
<?supplied-pmid 23112960?><pub-id pub-id-type="pmid">23112960</pub-id></mixed-citation></ref><ref id="pone.0217497.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Adams</surname><given-names>MJ</given-names></name>, <name><surname>Lefkowitz</surname><given-names>EJ</given-names></name>, <name><surname>King</surname><given-names>AMQ</given-names></name>, <name><surname>Harrach</surname><given-names>B</given-names></name>, <name><surname>Harrison</surname><given-names>RL</given-names></name>, <name><surname>Knowles</surname><given-names>NJ</given-names></name>, <etal>et al</etal>
<article-title>Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017)</article-title>. <source>Arch Virol</source>. <year>2017</year>;<volume>162</volume>(<issue>8</issue>):<fpage>2505</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-017-3358-5</pub-id> .<?supplied-pmid 28434098?><pub-id pub-id-type="pmid">28434098</pub-id></mixed-citation></ref><ref id="pone.0217497.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>Park</surname><given-names>JW</given-names></name>, <name><surname>Ramachandran</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Tseng</surname><given-names>YT</given-names></name>, <name><surname>Shen</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease</article-title>. <source>Hum Mol Genet</source>. <year>2016</year>;<volume>25</volume>(<issue>16</issue>):<fpage>3454</fpage>&#x02013;<lpage>66</lpage>. Epub 2016/07/04. <pub-id pub-id-type="doi">10.1093/hmg/ddw187</pub-id>
<?supplied-pmid 27378699?><pub-id pub-id-type="pmid">27378699</pub-id></mixed-citation></ref><ref id="pone.0217497.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>K&#x000f5;ks</surname><given-names>S</given-names></name>, <name><surname>Keermann</surname><given-names>M</given-names></name>, <name><surname>Reimann</surname><given-names>E</given-names></name>, <name><surname>Prans</surname><given-names>E</given-names></name>, <name><surname>Abram</surname><given-names>K</given-names></name>, <name><surname>Silm</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts</article-title>. <source>Front Med (Lausanne)</source>. <year>2016</year>;<volume>3</volume>:<fpage>46</fpage> Epub 2016/10/07. <pub-id pub-id-type="doi">10.3389/fmed.2016.00046</pub-id>
<?supplied-pmid 27774448?><pub-id pub-id-type="pmid">27774448</pub-id></mixed-citation></ref><ref id="pone.0217497.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Aversa</surname><given-names>R</given-names></name>, <name><surname>Sorrentino</surname><given-names>A</given-names></name>, <name><surname>Esposito</surname><given-names>R</given-names></name>, <name><surname>Ambrosio</surname><given-names>MR</given-names></name>, <name><surname>Amato</surname><given-names>A</given-names></name>, <name><surname>Zambelli</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer</article-title>. <source>Int J Mol Sci</source>. <year>2016</year>;<volume>17</volume>(<issue>1</issue>). Epub 2016/01/16. <pub-id pub-id-type="doi">10.3390/ijms17010121</pub-id>
<?supplied-pmid 26784191?><pub-id pub-id-type="pmid">26784191</pub-id></mixed-citation></ref><ref id="pone.0217497.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Annese</surname><given-names>A</given-names></name>, <name><surname>Manzari</surname><given-names>C</given-names></name>, <name><surname>Lionetti</surname><given-names>C</given-names></name>, <name><surname>Picardi</surname><given-names>E</given-names></name>, <name><surname>Horner</surname><given-names>DS</given-names></name>, <name><surname>Chiara</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Whole transcriptome profiling of Late-Onset Alzheimer's Disease patients provides insights into the molecular changes involved in the disease</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>4282</fpage> Epub 2018/03/09. <pub-id pub-id-type="doi">10.1038/s41598-018-22701-2</pub-id>
<?supplied-pmid 29523845?><pub-id pub-id-type="pmid">29523845</pub-id></mixed-citation></ref><ref id="pone.0217497.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>W</given-names></name>, <name><surname>Feng</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Zhong</surname><given-names>P</given-names></name>, <name><surname>Guo</surname><given-names>A</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing</article-title>. <source>Mol Med Rep</source>. <year>2017</year>;<volume>16</volume>(<issue>2</issue>):<fpage>2075</fpage>&#x02013;<lpage>88</lpage>. Epub 2017/06/23. <pub-id pub-id-type="doi">10.3892/mmr.2017.6855</pub-id>
<?supplied-pmid 28656315?><pub-id pub-id-type="pmid">28656315</pub-id></mixed-citation></ref><ref id="pone.0217497.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Sun</surname><given-names>S</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Yanli</surname><given-names>S</given-names></name>, <name><surname>Wuxiao</surname><given-names>Z</given-names></name>, <name><surname>Ge</surname><given-names>X</given-names></name>. <article-title>Transcriptome profiling and histology changes in juvenile blunt snout bream (Megalobrama amblycephala) liver tissue in response to acute thermal stress</article-title>. <source>Genomics</source>. <year>2018</year> Epub 2018/11/17. <pub-id pub-id-type="doi">10.1016/j.ygeno.2018.11.011</pub-id> .<?supplied-pmid 30458273?><pub-id pub-id-type="pmid">30458273</pub-id></mixed-citation></ref><ref id="pone.0217497.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Pinkham</surname><given-names>C</given-names></name>, <name><surname>Dahal</surname><given-names>B</given-names></name>, <name><surname>de la Fuente</surname><given-names>CL</given-names></name>, <name><surname>Bracci</surname><given-names>N</given-names></name>, <name><surname>Beitzel</surname><given-names>B</given-names></name>, <name><surname>Lindquist</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Alterations in the host transcriptome in vitro following Rift Valley fever virus infection</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>14385</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-14800-3</pub-id>
<?supplied-pmid 29085037?><pub-id pub-id-type="pmid">29085037</pub-id></mixed-citation></ref><ref id="pone.0217497.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Blomstrom</surname><given-names>AL</given-names></name>, <name><surname>Gu</surname><given-names>Q</given-names></name>, <name><surname>Barry</surname><given-names>G</given-names></name>, <name><surname>Wilkie</surname><given-names>G</given-names></name>, <name><surname>Skelton</surname><given-names>JK</given-names></name>, <name><surname>Baird</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Transcriptome analysis reveals the host response to Schmallenberg virus in bovine cells and antagonistic effects of the NSs protein</article-title>. <source>BMC Genomics</source>. <year>2015</year>;<volume>16</volume>:<fpage>324</fpage>
<pub-id pub-id-type="doi">10.1186/s12864-015-1538-9</pub-id>
<?supplied-pmid 25896169?><pub-id pub-id-type="pmid">25896169</pub-id></mixed-citation></ref><ref id="pone.0217497.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Glennon</surname><given-names>NB</given-names></name>, <name><surname>Jabado</surname><given-names>O</given-names></name>, <name><surname>Lo</surname><given-names>MK</given-names></name>, <name><surname>Shaw</surname><given-names>ML</given-names></name>. <article-title>Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions</article-title>. <source>J Virol</source>. <year>2015</year>;<volume>89</volume>(<issue>15</issue>):<fpage>7550</fpage>&#x02013;<lpage>66</lpage>. Epub 2015/05/13. <pub-id pub-id-type="doi">10.1128/JVI.00302-15</pub-id>
<?supplied-pmid 25972557?><pub-id pub-id-type="pmid">25972557</pub-id></mixed-citation></ref><ref id="pone.0217497.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Sessions</surname><given-names>OM</given-names></name>, <name><surname>Tan</surname><given-names>Y</given-names></name>, <name><surname>Goh</surname><given-names>KC</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Tan</surname><given-names>P</given-names></name>, <name><surname>Rozen</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Host cell transcriptome profile during wild-type and attenuated dengue virus infection</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>(<issue>3</issue>):<fpage>e2107</fpage> Epub 2013/03/14. <pub-id pub-id-type="doi">10.1371/journal.pntd.0002107</pub-id>
<?supplied-pmid 23516652?><pub-id pub-id-type="pmid">23516652</pub-id></mixed-citation></ref><ref id="pone.0217497.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Zhong</surname><given-names>H</given-names></name>, <name><surname>Hu</surname><given-names>X</given-names></name>, <name><surname>Janowski</surname><given-names>AB</given-names></name>, <name><surname>Storch</surname><given-names>GA</given-names></name>, <name><surname>Su</surname><given-names>L</given-names></name>, <name><surname>Cao</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>17775</fpage> Epub 2017/12/19. <pub-id pub-id-type="doi">10.1038/s41598-017-18195-z</pub-id>
<?supplied-pmid 29259291?><pub-id pub-id-type="pmid">29259291</pub-id></mixed-citation></ref><ref id="pone.0217497.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>D</given-names></name>, <name><surname>Pertea</surname><given-names>G</given-names></name>, <name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Pimentel</surname><given-names>H</given-names></name>, <name><surname>Kelley</surname><given-names>R</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>. <source>Genome Biol</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>R36</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id>
<?supplied-pmid 23618408?><pub-id pub-id-type="pmid">23618408</pub-id></mixed-citation></ref><ref id="pone.0217497.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Love</surname><given-names>MI</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>, <name><surname>Anders</surname><given-names>S</given-names></name>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>. <year>2014</year>;<volume>15</volume>(<issue>12</issue>):<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
<?supplied-pmid 25516281?><pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation></ref><ref id="pone.0217497.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Eden</surname><given-names>E</given-names></name>, <name><surname>Navon</surname><given-names>R</given-names></name>, <name><surname>Steinfeld</surname><given-names>I</given-names></name>, <name><surname>Lipson</surname><given-names>D</given-names></name>, <name><surname>Yakhini</surname><given-names>Z</given-names></name>. <article-title>GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists</article-title>. <source>BMC Bioinformatics</source>. <year>2009</year>;<volume>10</volume>:<fpage>48</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-10-48</pub-id>
<?supplied-pmid 19192299?><pub-id pub-id-type="pmid">19192299</pub-id></mixed-citation></ref><ref id="pone.0217497.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Supek</surname><given-names>F</given-names></name>, <name><surname>Bosnjak</surname><given-names>M</given-names></name>, <name><surname>Skunca</surname><given-names>N</given-names></name>, <name><surname>Smuc</surname><given-names>T</given-names></name>. <article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e21800</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id>
<?supplied-pmid 21789182?><pub-id pub-id-type="pmid">21789182</pub-id></mixed-citation></ref><ref id="pone.0217497.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Huang da</surname><given-names>W</given-names></name>, <name><surname>Sherman</surname><given-names>BT</given-names></name>, <name><surname>Lempicki</surname><given-names>RA</given-names></name>. <article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>;<volume>37</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id>
<?supplied-pmid 19033363?><pub-id pub-id-type="pmid">19033363</pub-id></mixed-citation></ref><ref id="pone.0217497.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>AT</given-names></name>, <name><surname>Arenillas</surname><given-names>DJ</given-names></name>, <name><surname>Worsley Hunt</surname><given-names>R</given-names></name>, <name><surname>Wasserman</surname><given-names>WW</given-names></name>. <article-title>oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets</article-title>. <source>G3 (Bethesda)</source>. <year>2012</year>;<volume>2</volume>(<issue>9</issue>):<fpage>987</fpage>&#x02013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1534/g3.112.003202</pub-id>
<?supplied-pmid 22973536?><pub-id pub-id-type="pmid">22973536</pub-id></mixed-citation></ref><ref id="pone.0217497.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>ET</given-names></name>, <name><surname>Airoldi</surname><given-names>EM</given-names></name>, <name><surname>Burge</surname><given-names>CB</given-names></name>. <article-title>Analysis and design of RNA sequencing experiments for identifying isoform regulation</article-title>. <source>Nat Methods</source>. <year>2010</year>;<volume>7</volume>(<issue>12</issue>):<fpage>1009</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1528</pub-id>
<?supplied-pmid 21057496?><pub-id pub-id-type="pmid">21057496</pub-id></mixed-citation></ref><ref id="pone.0217497.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Livak</surname><given-names>KJ</given-names></name>, <name><surname>Schmittgen</surname><given-names>TD</given-names></name>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source>. <year>2001</year>;<volume>25</volume>(<issue>4</issue>):<fpage>402</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id> .<?supplied-pmid 11846609?><pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation></ref><ref id="pone.0217497.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Brennan</surname><given-names>B</given-names></name>, <name><surname>Welch</surname><given-names>SR</given-names></name>, <name><surname>Elliott</surname><given-names>RM</given-names></name>. <article-title>The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>(<issue>2</issue>):<fpage>e1003922</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003922</pub-id>
<?supplied-pmid 24550727?><pub-id pub-id-type="pmid">24550727</pub-id></mixed-citation></ref><ref id="pone.0217497.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>J</given-names></name>, <name><surname>Coulouris</surname><given-names>G</given-names></name>, <name><surname>Zaretskaya</surname><given-names>I</given-names></name>, <name><surname>Cutcutache</surname><given-names>I</given-names></name>, <name><surname>Rozen</surname><given-names>S</given-names></name>, <name><surname>Madden</surname><given-names>TL</given-names></name>. <article-title>Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction</article-title>. <source>BMC Bioinformatics</source>. <year>2012</year>;<volume>13</volume>:<fpage>134</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-13-134</pub-id>
<?supplied-pmid 22708584?><pub-id pub-id-type="pmid">22708584</pub-id></mixed-citation></ref><ref id="pone.0217497.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Yadani</surname><given-names>FZ</given-names></name>, <name><surname>Kohl</surname><given-names>A</given-names></name>, <name><surname>Prehaud</surname><given-names>C</given-names></name>, <name><surname>Billecocq</surname><given-names>A</given-names></name>, <name><surname>Bouloy</surname><given-names>M</given-names></name>. <article-title>The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein</article-title>. <source>J Virol</source>. <year>1999</year>;<volume>73</volume>(<issue>6</issue>):<fpage>5018</fpage>&#x02013;<lpage>25</lpage>. <?supplied-pmid 10233964?><pub-id pub-id-type="pmid">10233964</pub-id></mixed-citation></ref><ref id="pone.0217497.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Le May</surname><given-names>N</given-names></name>, <name><surname>Dubaele</surname><given-names>S</given-names></name>, <name><surname>Proietti De Santis</surname><given-names>L</given-names></name>, <name><surname>Billecocq</surname><given-names>A</given-names></name>, <name><surname>Bouloy</surname><given-names>M</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name>. <article-title>TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus</article-title>. <source>Cell</source>. <year>2004</year>;<volume>116</volume>(<issue>4</issue>):<fpage>541</fpage>&#x02013;<lpage>50</lpage>. .<?supplied-pmid 14980221?><pub-id pub-id-type="pmid">14980221</pub-id></mixed-citation></ref><ref id="pone.0217497.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Kalveram</surname><given-names>B</given-names></name>, <name><surname>Lihoradova</surname><given-names>O</given-names></name>, <name><surname>Ikegami</surname><given-names>T</given-names></name>. <article-title>NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>13</issue>):<fpage>6234</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02255-10</pub-id>
<?supplied-pmid 21543505?><pub-id pub-id-type="pmid">21543505</pub-id></mixed-citation></ref><ref id="pone.0217497.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Drapkin</surname><given-names>R</given-names></name>, <name><surname>Reardon</surname><given-names>JT</given-names></name>, <name><surname>Ansari</surname><given-names>A</given-names></name>, <name><surname>Huang</surname><given-names>JC</given-names></name>, <name><surname>Zawel</surname><given-names>L</given-names></name>, <name><surname>Ahn</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II</article-title>. <source>Nature</source>. <year>1994</year>;<volume>368</volume>(<issue>6473</issue>):<fpage>769</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/368769a0</pub-id> .<?supplied-pmid 8152490?><pub-id pub-id-type="pmid">8152490</pub-id></mixed-citation></ref><ref id="pone.0217497.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Laine</surname><given-names>JP</given-names></name>, <name><surname>Mocquet</surname><given-names>V</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name>. <article-title>TFIIH enzymatic activities in transcription and nucleotide excision repair</article-title>. <source>Methods in enzymology</source>. <year>2006</year>;<volume>408</volume>:<fpage>246</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(06)08015-3</pub-id> .<?supplied-pmid 16793373?><pub-id pub-id-type="pmid">16793373</pub-id></mixed-citation></ref><ref id="pone.0217497.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Svejstrup</surname><given-names>JQ</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Feaver</surname><given-names>WJ</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Bushnell</surname><given-names>DA</given-names></name>, <name><surname>Donahue</surname><given-names>TF</given-names></name>, <etal>et al</etal>
<article-title>Different forms of TFIIH for transcription and DNA repair: holo-TFIIH and a nucleotide excision repairosome</article-title>. <source>Cell</source>. <year>1995</year>;<volume>80</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>8</lpage>. .<?supplied-pmid 7813015?><pub-id pub-id-type="pmid">7813015</pub-id></mixed-citation></ref><ref id="pone.0217497.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Di Pietro</surname><given-names>A</given-names></name>, <name><surname>Kajaste-Rudnitski</surname><given-names>A</given-names></name>, <name><surname>Oteiza</surname><given-names>A</given-names></name>, <name><surname>Nicora</surname><given-names>L</given-names></name>, <name><surname>Towers</surname><given-names>GJ</given-names></name>, <name><surname>Mechti</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation</article-title>. <source>J Virol</source>. <year>2013</year>;<volume>87</volume>(<issue>8</issue>):<fpage>4523</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02548-12</pub-id>
<?supplied-pmid 23408607?><pub-id pub-id-type="pmid">23408607</pub-id></mixed-citation></ref><ref id="pone.0217497.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Fasanaro</surname><given-names>P</given-names></name>, <name><surname>Greco</surname><given-names>S</given-names></name>, <name><surname>Lorenzi</surname><given-names>M</given-names></name>, <name><surname>Pescatori</surname><given-names>M</given-names></name>, <name><surname>Brioschi</surname><given-names>M</given-names></name>, <name><surname>Kulshreshtha</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>An integrated approach for experimental target identification of hypoxia-induced miR-210</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>50</issue>):<fpage>35134</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.052779</pub-id>
<?supplied-pmid 19826008?><pub-id pub-id-type="pmid">19826008</pub-id></mixed-citation></ref><ref id="pone.0217497.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Bavelloni</surname><given-names>A</given-names></name>, <name><surname>Ramazzotti</surname><given-names>G</given-names></name>, <name><surname>Poli</surname><given-names>A</given-names></name>, <name><surname>Piazzi</surname><given-names>M</given-names></name>, <name><surname>Focaccia</surname><given-names>E</given-names></name>, <name><surname>Blalock</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>MiRNA-210: A Current Overview</article-title>. <source>Anticancer Res</source>. <year>2017</year>;<volume>37</volume>(<issue>12</issue>):<fpage>6511</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.21873/anticanres.12107</pub-id> .<?supplied-pmid 29187425?><pub-id pub-id-type="pmid">29187425</pub-id></mixed-citation></ref><ref id="pone.0217497.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Narayanan</surname><given-names>A</given-names></name>, <name><surname>Popova</surname><given-names>T</given-names></name>, <name><surname>Turell</surname><given-names>M</given-names></name>, <name><surname>Kidd</surname><given-names>J</given-names></name>, <name><surname>Chertow</surname><given-names>J</given-names></name>, <name><surname>Popov</surname><given-names>SG</given-names></name>, <etal>et al</etal>
<article-title>Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e20354</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0020354</pub-id>
<?supplied-pmid 21655261?><pub-id pub-id-type="pmid">21655261</pub-id></mixed-citation></ref><ref id="pone.0217497.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Narayanan</surname><given-names>A</given-names></name>, <name><surname>Amaya</surname><given-names>M</given-names></name>, <name><surname>Voss</surname><given-names>K</given-names></name>, <name><surname>Chung</surname><given-names>M</given-names></name>, <name><surname>Benedict</surname><given-names>A</given-names></name>, <name><surname>Sampey</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Reactive oxygen species activate NFkappaB (p65) and p53 and induce apoptosis in RVFV infected liver cells</article-title>. <source>Virology</source>. <year>2014</year>;<volume>449</volume>:<fpage>270</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2013.11.023</pub-id> .<?supplied-pmid 24418562?><pub-id pub-id-type="pmid">24418562</pub-id></mixed-citation></ref><ref id="pone.0217497.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>MK</given-names></name>, <name><surname>Weinberg</surname><given-names>JB</given-names></name>. <article-title>Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets</article-title>. <source>Mediators Inflamm</source>. <year>2012</year>;<volume>2012</volume>:<fpage>236345</fpage>
<pub-id pub-id-type="doi">10.1155/2012/236345</pub-id>
<?supplied-pmid 22665949?><pub-id pub-id-type="pmid">22665949</pub-id></mixed-citation></ref><ref id="pone.0217497.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Moy</surname><given-names>RH</given-names></name>, <name><surname>Gold</surname><given-names>B</given-names></name>, <name><surname>Molleston</surname><given-names>JM</given-names></name>, <name><surname>Schad</surname><given-names>V</given-names></name>, <name><surname>Yanger</surname><given-names>K</given-names></name>, <name><surname>Salzano</surname><given-names>MV</given-names></name>, <etal>et al</etal>
<article-title>Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals</article-title>. <source>Immunity</source>. <year>2014</year>;<volume>40</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.020</pub-id>
<?supplied-pmid 24374193?><pub-id pub-id-type="pmid">24374193</pub-id></mixed-citation></ref><ref id="pone.0217497.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Hopkins</surname><given-names>KC</given-names></name>, <name><surname>Tartell</surname><given-names>MA</given-names></name>, <name><surname>Herrmann</surname><given-names>C</given-names></name>, <name><surname>Hackett</surname><given-names>BA</given-names></name>, <name><surname>Taschuk</surname><given-names>F</given-names></name>, <name><surname>Panda</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOP mRNAs restricts viral infection</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>22</issue>):<fpage>E2920</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1418805112</pub-id>
<?supplied-pmid 26038567?><pub-id pub-id-type="pmid">26038567</pub-id></mixed-citation></ref><ref id="pone.0217497.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Varga</surname><given-names>T</given-names></name>, <name><surname>Czimmerer</surname><given-names>Z</given-names></name>, <name><surname>Nagy</surname><given-names>L</given-names></name>. <article-title>PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation</article-title>. <source>Biochim Biophys Acta</source>. <year>2011</year>;<volume>1812</volume>(<issue>8</issue>):<fpage>1007</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2011.02.014</pub-id>
<?supplied-pmid 21382489?><pub-id pub-id-type="pmid">21382489</pub-id></mixed-citation></ref><ref id="pone.0217497.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>de la Fuente</surname><given-names>C</given-names></name>, <name><surname>Pinkham</surname><given-names>C</given-names></name>, <name><surname>Dabbagh</surname><given-names>D</given-names></name>, <name><surname>Beitzel</surname><given-names>B</given-names></name>, <name><surname>Garrison</surname><given-names>A</given-names></name>, <name><surname>Palacios</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>2</issue>):<fpage>e0191983</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0191983</pub-id>
<?supplied-pmid 29408900?><pub-id pub-id-type="pmid">29408900</pub-id></mixed-citation></ref><ref id="pone.0217497.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Dupuis-Maurin</surname><given-names>V</given-names></name>, <name><surname>Brinza</surname><given-names>L</given-names></name>, <name><surname>Baguet</surname><given-names>J</given-names></name>, <name><surname>Plantamura</surname><given-names>E</given-names></name>, <name><surname>Schicklin</surname><given-names>S</given-names></name>, <name><surname>Chambion</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Overexpression of the transcription factor Sp1 activates the OAS-RNAse L-RIG-I pathway</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e0118551</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0118551</pub-id>
<?supplied-pmid 25738304?><pub-id pub-id-type="pmid">25738304</pub-id></mixed-citation></ref><ref id="pone.0217497.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Frasor</surname><given-names>J</given-names></name>, <name><surname>El-Shennawy</surname><given-names>L</given-names></name>, <name><surname>Stender</surname><given-names>JD</given-names></name>, <name><surname>Kastrati</surname><given-names>I</given-names></name>. <article-title>NFkappaB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms</article-title>. <source>Mol Cell Endocrinol</source>. <year>2015</year>;<volume>418</volume>
<issue>Pt 3</issue>:<fpage>235</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2014.09.013</pub-id>
<?supplied-pmid 25450861?><pub-id pub-id-type="pmid">25450861</pub-id></mixed-citation></ref><ref id="pone.0217497.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Geiss</surname><given-names>GK</given-names></name>, <name><surname>Salvatore</surname><given-names>M</given-names></name>, <name><surname>Tumpey</surname><given-names>TM</given-names></name>, <name><surname>Carter</surname><given-names>VS</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Basler</surname><given-names>CF</given-names></name>, <etal>et al</etal>
<article-title>Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>16</issue>):<fpage>10736</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.112338099</pub-id>
<?supplied-pmid 12149435?><pub-id pub-id-type="pmid">12149435</pub-id></mixed-citation></ref><ref id="pone.0217497.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Okumu</surname><given-names>LA</given-names></name>, <name><surname>Forde</surname><given-names>N</given-names></name>, <name><surname>Fahey</surname><given-names>AG</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>E</given-names></name>, <name><surname>Roche</surname><given-names>JF</given-names></name>, <name><surname>Crowe</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>The effect of elevated progesterone and pregnancy status on mRNA expression and localisation of progesterone and oestrogen receptors in the bovine uterus</article-title>. <source>Reproduction</source>. <year>2010</year>;<volume>140</volume>(<issue>1</issue>):<fpage>143</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1530/REP-10-0113</pub-id> .<?supplied-pmid 20403910?><pub-id pub-id-type="pmid">20403910</pub-id></mixed-citation></ref><ref id="pone.0217497.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>L</given-names></name>, <name><surname>Xin</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Hao</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Cellular response to persistent foot-and-mouth disease virus infection is linked to specific types of alterations in the host cell transcriptome</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>5074</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-23478-0</pub-id>
<?supplied-pmid 29568077?><pub-id pub-id-type="pmid">29568077</pub-id></mixed-citation></ref><ref id="pone.0217497.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Batra</surname><given-names>R</given-names></name>, <name><surname>Stark</surname><given-names>TJ</given-names></name>, <name><surname>Clark</surname><given-names>E</given-names></name>, <name><surname>Belzile</surname><given-names>JP</given-names></name>, <name><surname>Wheeler</surname><given-names>EC</given-names></name>, <name><surname>Yee</surname><given-names>BA</given-names></name>, <etal>et al</etal>
<article-title>RNA-binding protein CPEB1 remodels host and viral RNA landscapes</article-title>. <source>Nat Struct Mol Biol</source>. <year>2016</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1101</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3310</pub-id>
<?supplied-pmid 27775709?><pub-id pub-id-type="pmid">27775709</pub-id></mixed-citation></ref><ref id="pone.0217497.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Boudreault</surname><given-names>S</given-names></name>, <name><surname>Martenon-Brodeur</surname><given-names>C</given-names></name>, <name><surname>Caron</surname><given-names>M</given-names></name>, <name><surname>Garant</surname><given-names>JM</given-names></name>, <name><surname>Tremblay</surname><given-names>MP</given-names></name>, <name><surname>Armero</surname><given-names>VE</given-names></name>, <etal>et al</etal>
<article-title>Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host Interactions</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>9</issue>):<fpage>e0161914</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0161914</pub-id>
<?supplied-pmid 27598998?><pub-id pub-id-type="pmid">27598998</pub-id></mixed-citation></ref><ref id="pone.0217497.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>J</given-names></name>, <name><surname>De Jesus</surname><given-names>PD</given-names></name>, <name><surname>Su</surname><given-names>V</given-names></name>, <name><surname>Han</surname><given-names>S</given-names></name>, <name><surname>Gong</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>NC</given-names></name>, <etal>et al</etal>
<article-title>RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I interferon production</article-title>. <source>J Virol</source>. <year>2014</year>;<volume>88</volume>(<issue>14</issue>):<fpage>7987</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00643-14</pub-id>
<?supplied-pmid 24807708?><pub-id pub-id-type="pmid">24807708</pub-id></mixed-citation></ref><ref id="pone.0217497.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Takashima</surname><given-names>K</given-names></name>, <name><surname>Oshiumi</surname><given-names>H</given-names></name>, <name><surname>Takaki</surname><given-names>H</given-names></name>, <name><surname>Matsumoto</surname><given-names>M</given-names></name>, <name><surname>Seya</surname><given-names>T</given-names></name>. <article-title>RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response</article-title>. <source>Cell reports</source>. <year>2015</year>;<volume>11</volume>(<issue>2</issue>):<fpage>192</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.027</pub-id> .<?supplied-pmid 25865883?><pub-id pub-id-type="pmid">25865883</pub-id></mixed-citation></ref><ref id="pone.0217497.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Stoilov</surname><given-names>P</given-names></name>, <name><surname>Daoud</surname><given-names>R</given-names></name>, <name><surname>Nayler</surname><given-names>O</given-names></name>, <name><surname>Stamm</surname><given-names>S</given-names></name>. <article-title>Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA</article-title>. <source>Hum Mol Genet</source>. <year>2004</year>;<volume>13</volume>(<issue>5</issue>):<fpage>509</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh051</pub-id> .<?supplied-pmid 14709600?><pub-id pub-id-type="pmid">14709600</pub-id></mixed-citation></ref><ref id="pone.0217497.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Glatz</surname><given-names>DC</given-names></name>, <name><surname>Rujescu</surname><given-names>D</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>, <name><surname>Berendt</surname><given-names>FJ</given-names></name>, <name><surname>Hartmann</surname><given-names>AM</given-names></name>, <name><surname>Faltraco</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease</article-title>. <source>J Neurochem</source>. <year>2006</year>;<volume>96</volume>(<issue>3</issue>):<fpage>635</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03552.x</pub-id> .<?supplied-pmid 16371011?><pub-id pub-id-type="pmid">16371011</pub-id></mixed-citation></ref><ref id="pone.0217497.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Hillman</surname><given-names>RT</given-names></name>, <name><surname>Green</surname><given-names>RE</given-names></name>, <name><surname>Brenner</surname><given-names>SE</given-names></name>. <article-title>An unappreciated role for RNA surveillance</article-title>. <source>Genome Biol</source>. <year>2004</year>;<volume>5</volume>(<issue>2</issue>):<fpage>R8</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2004-5-2-r8</pub-id>
<?supplied-pmid 14759258?><pub-id pub-id-type="pmid">14759258</pub-id></mixed-citation></ref><ref id="pone.0217497.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Stevenson</surname><given-names>RJ</given-names></name>, <name><surname>Hamilton</surname><given-names>SJ</given-names></name>, <name><surname>MacCallum</surname><given-names>DE</given-names></name>, <name><surname>Hall</surname><given-names>PA</given-names></name>, <name><surname>Fuller-Pace</surname><given-names>FV</given-names></name>. <article-title>Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus</article-title>. <source>J Pathol</source>. <year>1998</year>;<volume>184</volume>(<issue>4</issue>):<fpage>351</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9896(199804)184:4&#x0003c;351::AID-PATH1235&#x0003e;3.0.CO;2-C</pub-id> .<?supplied-pmid 9664900?><pub-id pub-id-type="pmid">9664900</pub-id></mixed-citation></ref><ref id="pone.0217497.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Rossler</surname><given-names>OG</given-names></name>, <name><surname>Hloch</surname><given-names>P</given-names></name>, <name><surname>Schutz</surname><given-names>N</given-names></name>, <name><surname>Weitzenegger</surname><given-names>T</given-names></name>, <name><surname>Stahl</surname><given-names>H</given-names></name>. <article-title>Structure and expression of the human p68 RNA helicase gene</article-title>. <source>Nucleic Acids Res</source>. <year>2000</year>;<volume>28</volume>(<issue>4</issue>):<fpage>932</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.4.932</pub-id>
<?supplied-pmid 10648785?><pub-id pub-id-type="pmid">10648785</pub-id></mixed-citation></ref><ref id="pone.0217497.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>HC</given-names></name>, <name><surname>Johnston</surname><given-names>M</given-names></name>, <name><surname>Nicol</surname><given-names>SM</given-names></name>, <name><surname>Bourdon</surname><given-names>JC</given-names></name>, <name><surname>Thompson</surname><given-names>AM</given-names></name>, <name><surname>Hutvagner</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>An evolutionarily conserved, alternatively spliced, intron in the p68/DDX5 DEAD-box RNA helicase gene encodes a novel miRNA</article-title>. <source>RNA</source>. <year>2011</year>;<volume>17</volume>(<issue>4</issue>):<fpage>555</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1261/rna.2591611</pub-id>
<?supplied-pmid 21346006?><pub-id pub-id-type="pmid">21346006</pub-id></mixed-citation></ref><ref id="pone.0217497.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Wonderlich</surname><given-names>ER</given-names></name>, <name><surname>Caroline</surname><given-names>AL</given-names></name>, <name><surname>McMillen</surname><given-names>CM</given-names></name>, <name><surname>Walters</surname><given-names>AW</given-names></name>, <name><surname>Reed</surname><given-names>DS</given-names></name>, <name><surname>Barratt-Boyes</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis</article-title>. <source>J Virol</source>. <year>2018</year>;<volume>92</volume>(<issue>3</issue>). <pub-id pub-id-type="doi">10.1128/JVI.01662-17</pub-id>
<?supplied-pmid 29118127?><pub-id pub-id-type="pmid">29118127</pub-id></mixed-citation></ref><ref id="pone.0217497.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>McElroy</surname><given-names>AK</given-names></name>, <name><surname>Nichol</surname><given-names>ST</given-names></name>. <article-title>Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection</article-title>. <source>Virology</source>. <year>2012</year>;<volume>422</volume>(<issue>1</issue>):<fpage>6</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2011.09.023</pub-id> .<?supplied-pmid 22018491?><pub-id pub-id-type="pmid">22018491</pub-id></mixed-citation></ref><ref id="pone.0217497.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Bird</surname><given-names>BH</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name><surname>Nichol</surname><given-names>ST</given-names></name>, <name><surname>Maclachlan</surname><given-names>NJ</given-names></name>. <article-title>Rift Valley fever virus</article-title>. <source>J Am Vet Med Assoc</source>. <year>2009</year>;<volume>234</volume>(<issue>7</issue>):<fpage>883</fpage>&#x02013;<lpage>93</lpage>. Epub 2009/04/02. <pub-id pub-id-type="doi">10.2460/javma.234.7.883</pub-id> .<?supplied-pmid 19335238?><pub-id pub-id-type="pmid">19335238</pub-id></mixed-citation></ref><ref id="pone.0217497.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>RM</given-names></name>, <name><surname>Weber</surname><given-names>F</given-names></name>. <article-title>Bunyaviruses and the type I interferon system</article-title>. <source>Viruses</source>. <year>2009</year>;<volume>1</volume>(<issue>3</issue>):<fpage>1003</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3390/v1031003</pub-id>
<?supplied-pmid 21994579?><pub-id pub-id-type="pmid">21994579</pub-id></mixed-citation></ref><ref id="pone.0217497.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Weber</surname><given-names>F</given-names></name>, <name><surname>Wagner</surname><given-names>V</given-names></name>, <name><surname>Rasmussen</surname><given-names>SB</given-names></name>, <name><surname>Hartmann</surname><given-names>R</given-names></name>, <name><surname>Paludan</surname><given-names>SR</given-names></name>. <article-title>Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses</article-title>. <source>J Virol</source>. <year>2006</year>;<volume>80</volume>(<issue>10</issue>):<fpage>5059</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.80.10.5059-5064.2006</pub-id>
<?supplied-pmid 16641297?><pub-id pub-id-type="pmid">16641297</pub-id></mixed-citation></ref><ref id="pone.0217497.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Habjan</surname><given-names>M</given-names></name>, <name><surname>Andersson</surname><given-names>I</given-names></name>, <name><surname>Klingstrom</surname><given-names>J</given-names></name>, <name><surname>Schumann</surname><given-names>M</given-names></name>, <name><surname>Martin</surname><given-names>A</given-names></name>, <name><surname>Zimmermann</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction</article-title>. <source>PLoS One</source>. <year>2008</year>;<volume>3</volume>(<issue>4</issue>):<fpage>e2032</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0002032</pub-id>
<?supplied-pmid 18446221?><pub-id pub-id-type="pmid">18446221</pub-id></mixed-citation></ref><ref id="pone.0217497.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Habjan</surname><given-names>M</given-names></name>, <name><surname>Pichlmair</surname><given-names>A</given-names></name>, <name><surname>Elliott</surname><given-names>RM</given-names></name>, <name><surname>Overby</surname><given-names>AK</given-names></name>, <name><surname>Glatter</surname><given-names>T</given-names></name>, <name><surname>Gstaiger</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase</article-title>. <source>J Virol</source>. <year>2009</year>;<volume>83</volume>(<issue>9</issue>):<fpage>4365</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02148-08</pub-id>
<?supplied-pmid 19211744?><pub-id pub-id-type="pmid">19211744</pub-id></mixed-citation></ref><ref id="pone.0217497.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Le May</surname><given-names>N</given-names></name>, <name><surname>Mansuroglu</surname><given-names>Z</given-names></name>, <name><surname>Leger</surname><given-names>P</given-names></name>, <name><surname>Josse</surname><given-names>T</given-names></name>, <name><surname>Blot</surname><given-names>G</given-names></name>, <name><surname>Billecocq</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells</article-title>. <source>PLoS Pathog</source>. <year>2008</year>;<volume>4</volume>(<issue>1</issue>):<fpage>e13</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.0040013</pub-id>
<?supplied-pmid 18225953?><pub-id pub-id-type="pmid">18225953</pub-id></mixed-citation></ref><ref id="pone.0217497.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Benferhat</surname><given-names>R</given-names></name>, <name><surname>Josse</surname><given-names>T</given-names></name>, <name><surname>Albaud</surname><given-names>B</given-names></name>, <name><surname>Gentien</surname><given-names>D</given-names></name>, <name><surname>Mansuroglu</surname><given-names>Z</given-names></name>, <name><surname>Marcato</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome</article-title>. <source>J Virol</source>. <year>2012</year>;<volume>86</volume>(<issue>20</issue>):<fpage>11333</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01549-12</pub-id>
<?supplied-pmid 22896612?><pub-id pub-id-type="pmid">22896612</pub-id></mixed-citation></ref><ref id="pone.0217497.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Harizi</surname><given-names>H</given-names></name>, <name><surname>Corcuff</surname><given-names>JB</given-names></name>, <name><surname>Gualde</surname><given-names>N</given-names></name>. <article-title>Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology</article-title>. <source>Trends Mol Med</source>. <year>2008</year>;<volume>14</volume>(<issue>10</issue>):<fpage>461</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2008.08.005</pub-id> .<?supplied-pmid 18774339?><pub-id pub-id-type="pmid">18774339</pub-id></mixed-citation></ref><ref id="pone.0217497.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>B</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Geng</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Yao</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>7</issue>):<fpage>e41365</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0041365</pub-id>
<?supplied-pmid 22911786?><pub-id pub-id-type="pmid">22911786</pub-id></mixed-citation></ref><ref id="pone.0217497.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Werder</surname><given-names>RB</given-names></name>, <name><surname>Lynch</surname><given-names>JP</given-names></name>, <name><surname>Simpson</surname><given-names>JC</given-names></name>, <name><surname>Zhang</surname><given-names>V</given-names></name>, <name><surname>Hodge</surname><given-names>NH</given-names></name>, <name><surname>Poh</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-</article-title>. <source>Sci Transl Med</source>. <year>2018</year>;<volume>10</volume>(<issue>440</issue>). <pub-id pub-id-type="doi">10.1126/scitranslmed.aao0052</pub-id> .<?supplied-pmid 29743346?><pub-id pub-id-type="pmid">29743346</pub-id></mixed-citation></ref><ref id="pone.0217497.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>YJ</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Rio</surname><given-names>DC</given-names></name>. <article-title>Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5</article-title>. <source>Genes Dev</source>. <year>2018</year>;<volume>32</volume>(<issue>15&#x02013;16</issue>):<fpage>1060</fpage>&#x02013;<lpage>74</lpage>. Epub 2018/07/24. <pub-id pub-id-type="doi">10.1101/gad.316034.118</pub-id>
<?supplied-pmid 30042133?><pub-id pub-id-type="pmid">30042133</pub-id></mixed-citation></ref><ref id="pone.0217497.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Dichmann</surname><given-names>DS</given-names></name>, <name><surname>Walentek</surname><given-names>P</given-names></name>, <name><surname>Harland</surname><given-names>RM</given-names></name>. <article-title>The alternative splicing regulator Tra2b is required for somitogenesis and regulates splicing of an inhibitory Wnt11b isoform</article-title>. <source>Cell Rep</source>. <year>2015</year>;<volume>10</volume>(<issue>4</issue>):<fpage>527</fpage>&#x02013;<lpage>36</lpage>. Epub 2015/01/22. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.046</pub-id>
<?supplied-pmid 25620705?><pub-id pub-id-type="pmid">25620705</pub-id></mixed-citation></ref><ref id="pone.0217497.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Yoshida</surname><given-names>T</given-names></name>, <name><surname>Kim</surname><given-names>JH</given-names></name>, <name><surname>Carver</surname><given-names>K</given-names></name>, <name><surname>Su</surname><given-names>Y</given-names></name>, <name><surname>Weremowicz</surname><given-names>S</given-names></name>, <name><surname>Mulvey</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer</article-title>. <source>Cancer Res</source>. <year>2015</year>;<volume>75</volume>(<issue>7</issue>):<fpage>1516</fpage>&#x02013;<lpage>26</lpage>. Epub 2015/02/10. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-2443</pub-id> .<?supplied-pmid 25670169?><pub-id pub-id-type="pmid">25670169</pub-id></mixed-citation></ref><ref id="pone.0217497.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>L</given-names></name>, <name><surname>Vlasova-St Louis</surname><given-names>I</given-names></name>, <name><surname>Bohjanen</surname><given-names>PR</given-names></name>. <article-title>Viral manipulation of host mRNA decay</article-title>. <source>Future Virol</source>. <year>2018</year>;<volume>13</volume>(<issue>3</issue>):<fpage>211</fpage>&#x02013;<lpage>23</lpage>. Epub 2018/02/23. <pub-id pub-id-type="doi">10.2217/fvl-2017-0106</pub-id>
<?supplied-pmid 29750084?><pub-id pub-id-type="pmid">29750084</pub-id></mixed-citation></ref><ref id="pone.0217497.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>YC</given-names></name>, <name><surname>Kuo</surname><given-names>RL</given-names></name>, <name><surname>Lin</surname><given-names>JY</given-names></name>, <name><surname>Huang</surname><given-names>PN</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Cytoplasmic viral RNA-dependent RNA polymerase disrupts the intracellular splicing machinery by entering the nucleus and interfering with Prp8</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e1004199</fpage> Epub 2014/06/26. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004199</pub-id>
<?supplied-pmid 24968230?><pub-id pub-id-type="pmid">24968230</pub-id></mixed-citation></ref><ref id="pone.0217497.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>DLV</given-names></name>, <name><surname>Tellier</surname><given-names>M</given-names></name>, <name><surname>Mart&#x000ed;nez-Alonso</surname><given-names>M</given-names></name>, <name><surname>Nojima</surname><given-names>T</given-names></name>, <name><surname>Proudfoot</surname><given-names>NJ</given-names></name>, <name><surname>Murphy</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Influenza Virus Mounts a Two-Pronged Attack on Host RNA Polymerase II Transcription</article-title>. <source>Cell Rep</source>. <year>2018</year>;<volume>23</volume>(<issue>7</issue>):<fpage>2119</fpage>&#x02013;<lpage>29</lpage>.e3. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.047</pub-id>
<?supplied-pmid 29768209?><pub-id pub-id-type="pmid">29768209</pub-id></mixed-citation></ref><ref id="pone.0217497.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Barnhart</surname><given-names>MD</given-names></name>, <name><surname>Moon</surname><given-names>SL</given-names></name>, <name><surname>Emch</surname><given-names>AW</given-names></name>, <name><surname>Wilusz</surname><given-names>CJ</given-names></name>, <name><surname>Wilusz</surname><given-names>J</given-names></name>. <article-title>Changes in cellular mRNA stability, splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus</article-title>. <source>Cell Rep</source>. <year>2013</year>;<volume>5</volume>(<issue>4</issue>):<fpage>909</fpage>&#x02013;<lpage>17</lpage>. Epub 2013/11/07. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.012</pub-id>
<?supplied-pmid 24210824?><pub-id pub-id-type="pmid">24210824</pub-id></mixed-citation></ref><ref id="pone.0217497.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>De Maio</surname><given-names>FA</given-names></name>, <name><surname>Risso</surname><given-names>G</given-names></name>, <name><surname>Iglesias</surname><given-names>NG</given-names></name>, <name><surname>Shah</surname><given-names>P</given-names></name>, <name><surname>Pozzi</surname><given-names>B</given-names></name>, <name><surname>Gebhard</surname><given-names>LG</given-names></name>, <etal>et al</etal>
<article-title>The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and Modulates Splicing</article-title>. <source>PLoS Pathog</source>. <year>2016</year>;<volume>12</volume>(<issue>8</issue>):<fpage>e1005841</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1005841</pub-id> .<?supplied-pmid 27575636?><pub-id pub-id-type="pmid">27575636</pub-id></mixed-citation></ref></ref-list></back></article>